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Background Sexual risk behaviour is the underlying driving force of HIV transmission. The 
discovery and introduction of antiretroviral therapy (ART) has led to significant changes in the 
treatment and management of HIV, the benefits of which manifest as reduced viral load and 
consequently attenuated morbidity and mortality in HIV-infected individuals. As the benefits of 
ART are realized, prevention research is increasingly focusing on the sexual risk behaviour of sub-
populations of HIV-infected individuals with known positive serostatus, who are at high risk of 
transmitting HIV. This study examines the levels of sexual risk behaviour of HIV-infected 
individuals seeking care across different service settings in Cape Town, South Africa. Furthermore, it 
seeks to understand the risk factors associated with sexual activity that could lead to secondary 
transmission. 
Methods This cross-sectional study randomly selected 459 male and female clinic attendees aged 
between 18 and 68 years from two primary health care service settings in Cape Town. All 
participants were HIV-infected and attending either VCT services, PMTCT services, HIV care or 
ARV treatment services. Data were collected by means of a structured questionnaire which included 
items on sexual activity and sexual risk behaviour; socio-demographic characteristics and self-
reported health status and well-being. Bivariate and multivariate analyses were performed to 
determine the levels of sexual activity pertaining to different service settings, and by ARV treatment 
status. The determinants of sexual risk behaviour in the sample were examined. 
Results Higher levels of sexual activity were observed in this setting than those found in similar 
African settings. No significant differences in sexual activity were found between ARV-treated and 
treatment naïve participants or across health services. Men were half as likely as women to report 
sexual activity in the past month and educational level was a positive predictor of decreased sexual 
activity. Individuals who were on ARV treatment were three times as likely as those not on 
treatment to have used a condom during their last sexual event. Although they reported lower levels 
of sexual activity, men were more than three times as likely to report more than one sexual partner 
in the past six months. 
Conclusion In comparison to other research in this area, both in Africa and beyond, the sexual 
activity and associated risk behaviour among these HIV-infected individuals show both similarities 
and differences. This underscores the need for tailored policy recommendations and prevention 
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An estimated 2 million deaths due to AIDS occurred in 2007; 75% of these occurred in sub-Saharan 
Africa (UNAIDS, 2008). While HIV prevalence is reported to be stabilizing on the African 
continent, AIDS remains the leading cause of death (UNAIDS, 2008). Southern African countries 
bear the heaviest disease burden, with 35% of all new infections and 38% of all AIDS-related deaths 
occurring in this region in 2007 (UNAIDS, 2008, UNAIDS and World Health Organisation, 2007). 
South Africa has the largest number of HIV infections in the world, with a national antenatal 
seroprevalence of 28% in 2007 (Department of Health, 2007). Prevalence has been estimated by 
UNAIDS to be as high as 17% in females aged 15-24 years in 2007 (UNAIDS, 2008). 
 There is considerable geographic variation in the distribution of HIV. The differential global 
trajectories of the epidemic can be explained to a great extent by the differences in transmission 
dynamics which are primarily driven by sexual risk behaviour. Sexual risk behaviour constitutes a 
constellation of sexual practices which are deemed “unsafe”, consequently placing an individual at 
risk of acquiring infection. Risk is modified by the presence and extent of several behavioural 
dimensions including the number of sexual partners acquired; the characteristics of these sexual 
partners and the nature of such partnerships; the frequency and mode of sex acts. Protective 
behaviours which mitigate risk include the frequency of protected sexual intercourse through barrier 
method use (Aral, 2004, Aral et al., 2007, Slaymaker, 2004).  
Sexual risk behaviour varies at population and sub-group level, hence it changes between 
contexts and over time. Populations are heterogeneous, each with structural and individual-level 
features that contribute to differential settings for the transmission of HIV (Aral et al., 2007). 
Despite this variation, sexual risk behaviour is the universal and underlying driving force of HIV 
transmission, with approximately 85% of all current infections being attributed to sexual 
transmission (Piot et al., 2008). While initial prevention efforts targeted those at high risk of 
acquiring HIV, more recently the focus has shifted to identifying and understanding the sexual risk 
behaviour of sub-populations of HIV-infected individuals with known positive serostatus, who are 
at risk of transmitting HIV, with a view to developing more serostatus-specific prevention 
interventions (Crepaz and Marks, 2002). 
Early research in high risk sub-populations in developed country settings initially confirmed 
speculation surrounding the association between increased sexual risk behaviour and widespread 
antiretroviral (ARV) treatment initiation in men who have sex with men (MSM). Observed 
behavioural change was referred to as „treatment optimism‟, and it was based on the premise that 











(antiretroviral therapy) improves and prolongs life, could lead to complacency around safer sexual 
practices (Ciesielski, 2003). Since then however, these findings have been challenged in light of 
accumulated evidence of discrepant associations between increased sexual activity and assumptions 
concerning treatment optimism in developed settings. Much of this discrepancy can be attributed to 
the complexity of the association between sexual risk behaviour and HIV transmission across 
locations which are a result of the underlying heterogeneity of populations experiencing HIV 
epidemics. Furthermore, there is evidence to suggest that increases in sexual risk behaviour have 
occurred independently of the perception that ART mitigates the risk and consequences of HIV 
transmission (Elford, 2006, Grassly et al., 2001).  
The discovery and introduction of antiretroviral therapy  in 1996 heralded significant changes 
in the treatment and management of HIV, the benefits of which manifested as reduced viral load 
and consequently attenuated morbidity and mortality in HIV-infected individuals (Quinn, 2008). In 
particular, while HIV is increasingly becoming manageable as a chronic illness, both long-and short-
term clinical and socio-behavioural improvements in health-related quality of life (HRQL) in 
individuals who are on ART are being observed (Jelsma et al., 2005a, Protopopescu et al., 2007). 
Although research into the HRQL of individuals on ART has been carried out in developing 
countries, the impact of improved prognosis after treatment initiation on sexual risk behaviour in 
developing country settings is less well understood. The mix of transmission dynamics involving 
predominantly heterosexual high risk behaviour, delayed treatment roll out as well as limited 
coverage and access to care underscore the differential impact of treatment on secondary 
transmission between HIV negative individuals and those of known positive serostatus in these 
settings (Quinn, 2008).  
With many treatment programmes still in their infancy, little is known about the short-term 
effect of ART on sexual risk behaviour in developing countries (Kennedy et al., 2007, Salomon and 
Hogan, 2008). South Africa is no exception. While ART has been made available since 2004, roll out 
of programmes and treatment scale-up has not happened uniformly across provinces. Access to 
treatment has been hampered by a mix of health system challenges, including service- and patient-
driven factors (Johnson, 2007). While perceptions and behaviour surrounding sexual risk seem to be 
positively influenced by the introduction of improved HIV testing and ART services in local 
settings, HIV transmission rates have been reported to continue to rise unabated. Despite good 
coverage and awareness of HIV prevention interventions, high rates of sexual risk behaviour are still 
observed (Boulle et al., 2008, Hendriksen et al., 2007, Shisana et al., 2005, Versteeg and Murray, 
2008). Evidence from recent South African research suggests that the prevalence of sexual risk 











Furthermore, as life expectancy of HIV-infected individuals is extended due to the effect of 
treatment, so new interest in the health-related quality of life of HIV-infected individuals has been 
generated, not least amid concerns about increased behavioural „disinhibition‟, suggesting that 
individuals receiving ART might engage in riskier sexual behaviour than they would have if they 
were not on ART, if they believe that by being on ART, they are reducing their own infectivity 
through lowered viral load (Elford, 2006, Elford et al., 2002). With increasing numbers of HIV-
infected individuals moving onto treatment and living healthier and longer lives, so the study of 
sexual health and behaviour among these individuals and factors which increase risk of transmission 
to their partners of HIV-negative or unknown status (known as secondary transmission) has become 
increasingly important to inform policy and prevention. 
The aim of this study is to examine the levels of sexual risk behaviour of HIV-infected 
individuals attending voluntary counselling and testing (VCT), prevention of mother-to-child 
transmission (PMTCT), HIV care and antiretroviral (ART) treatment services in Cape Town, South 
Africa. More specifically, it seeks to understand the risk factors associated with sexual activity 
(defined per study protocol as penetrative vaginal or anal intercourse) that could lead to secondary 
transmission. Since data is sourced from respondents attending distinct services, it is possible to 
investigate the potential variation in sexual risk behaviour across different service settings. In 
particular, having four service settings to hand provides an opportunity to examine potential 
differences in sexual risk behaviour between those who have been recently diagnosed (PMTCT and 
VCT services) and those who have had longer exposure to care (HIV and ART services). Finally, the 
study seeks to examine the association between improved health-related quality of life and sexual 
risk behaviour. The following research questions are posed:  
 
1. What are the levels of sexual activity and different forms of sexual risk behaviour among 
HIV-infected individuals either accessing ART treatment or other HIV-related services? 
2. What are the determinants of sexual activity in HIV-infected individuals? 
3. Which factors are associated with unprotected sex and barrier method use, and multiple 
partner acquisition among sexually active HIV-infected individuals? 
4. Is there an association between being on ARV treatment and sexual risk behaviour? 
5. Is the time since HIV diagnosis, or disclosure status or health-related quality of life 
correlated with sexual risk taking in HIV-infected individuals? 
As ART becomes increasingly available in South Africa, so it becomes imperative to understand the 











effectively target individuals of known positive serostatus who are at risk of secondary transmission 












2 LITERATURE REVIEW 
2.1 The epidemiology of HIV in South Africa 
In South Africa, HIV was first introduced into the heterosexual population through cross-country 
migration patterns in the Southern African region (Williams and Gouws, 2001). In 1990, South 
African HIV prevalence among women attending antenatal clinics was 0.7% (Department of Health, 
2008). Doubling time at the start of the epidemic was approximately 15 months, and by 1994 
antenatal clinic HIV prevalence had increased to 10%, indicating a rapid spread from high-risk 
groups to the general population (Williams et al., 2000). Antenatal clinic data showed a continued 
rise in prevalence which has currently levelled off at 28% (Department of Health, 2007). 
Factors facilitating early spread included circular migration patterns of labour and the high 
prevalence of curable and incurable STIs in urban and rural populations (Williams and Gouws, 
2001). The seasonal migrant labour system linked to the South African gold mines drew a substantial 
work force from neighbouring countries as well as workers from within South Africa. Single-sex 
hostel dwelling for periods of up to six months placed migrant workers at high risk of STIs and HIV 
acquisition through commercial sex, followed by transmission to stable sex partners upon returning 
home (Lurie, 2000, Campbell, 2003). High prevalence of bacterial and viral STIs in sentinel 
populations, including antenatal and STI clinic attendees and sex workers, were indicated by the 
limited access to treatment services and poor diagnosis and management of STIs, rendering high risk 
groups more vulnerable to HIV transmission (Johnson, 2007, Johnson et al., 2005). 
A mix of biological, social and economic factors has ensured that women have borne the 
highest burden of infection in South Africa. As the epidemic entered a mature stage after 2000, 
women aged 15-49 years were estimated to account for 49.5% of all infections (Dorrington et al., 
2002). Socio-demographic disparities by age and sex continue to be marked: 37% of all new 
infections occurred in adults between 15-24 years in 2007, with HIV prevalence among males in this 
age group being 4%, yet 22% among females in the same age group (UNAIDS, 2008).  
2.2 Sexual risk behaviour as a determinant of HIV transmission 
Mathematical models and epidemiological studies on HIV transmission have done much to explain 
changes in transmission dynamics and sexual risk behaviour across settings and over time (Aral et 
al., 2005, Cassels et al., 2008). The transmission dynamics of HIV, as applied to other sexually 











average rate of contact between infected and susceptible individuals, the efficiency of transmission 
from infected individual to susceptible partner, and the average duration of infectiousness (May and 
Anderson, 1987, Royce et al., 1997).  
Contact rates are dependent on both the rate of partner acquisition and the frequency of sex 
within partnerships, yet sexual partnerships and the probability of HIV transmission do not occur at 
random. They are, rather, dependent on an array of political, economic, cultural, geographical 
factors, as well as those relating to health service delivery. Consequently the social patterns and 
sexual behaviour of some individuals contribute more to the spread of HIV than others (Day et al., 
1998). “Core groups” or vulnerable sub-populations comprising sex workers, men who have sex 
with men (MSM), truck drivers or migrant labourers have been identified as major role players in 
spreading and sustaining HIV epidemics. As high risk transmitters, their sexual behaviour is 
characterised by elevated rates of partner acquisition and high frequency of sex acts (Thomas and 
Tucker, 1996). In settings where rates of sexual risk behaviour are low in the general population, 
infection is likely to increase exponentially within core groups. Such sexual activity either results in a 
locally concentrated epidemic that remains within the core group or a truncated epidemic, which 
shifts to low risk sub-populations as a consequence of individual movement from the core group to 
stable sexual partnerships (Aral et al., 2007). 
The role of mixing patterns or sexual networks is another feature of contact-related 
transmission. Such networks “bridge” core groups with low risk peripheral sub-populations and 
have the potential to increase general population prevalence. Once population prevalence is exceeds 
1% in adults aged 15-59 years, and 5% in core groups, the epidemic moves to a generalized state. In 
such settings prevalence remains disproportionately higher in core groups, but is maintained through 
widespread sexual risk behaviour in the general population (Hellringer and Kohler, 2007, UNAIDS, 
2008). 
Demographic and health survey data have shown that individuals in sub-Saharan Africa are 
more likely to have concurrent rather than multiple serial partners than people in other parts of the 
world (Garnett and Johnson, 1997, Halperin and Epstein, 2004). However, evidence from a study in 
5 African cities found no association between concurrency and HIV spread (Lagarde et al., 2001). 
Mathematical models of the spread of HIV have estimated that the potential effect of concurrency 
on disease transmission is considerable even when the average frequency of partner change remains 
constant. Since concurrent relationships can be viewed as small networks, members are at a higher 
risk of infection than if they were serially monogamous (Morris and Kretzschmar, 1997).  
Substantial variation in the risk of transmission has been associated with duration of 











infection has been associated with a twelve-fold increase in the probability of infection due to peak 
viral load, while late stage infection has been associated with an approximately fivefold increase in 
the transmission risk (Wawer et al., 2005). The combined effect of acute infection in concurrent 
networks may  amplify transmission through chains of sexual partnerships incorporating newly 
infected individuals and susceptibles (Morris and Kretzschmar, 1997). 
Transmission risk is further elevated in the presence of other STIs, which biologically interact 
with HIV to increase both infectiousness and susceptibility (Low et al., 2006). Although reciprocity 
is lower in non-ulcerative STIs, transmission rates are higher due to higher prevalence of non-
ulcerative STIs in most populations affected by HIV. With ulcerative STIs, transmission is bi-
directional (Fleming and Wasserheit, 1999). In particular, the risk of acquiring HIV is two to three 
times higher in the presence of herpes simplex virus type 2 (HSV-2) co-infection (Freeman et al., 
2006, McClelland et al., 2002, van de Perre et al., 2008, Wald and Link, 2002, Wasserheit, 1992) . 
2.3 Determinants of sexual risk behaviour 
The intrinsic driver of  differential disease spread within populations is sexual risk behaviour. Much 
has been written about sexual networks and the strong association between gender, poverty and the 
high prevalence of transactional sex and age-mixing in South Africa, which highlights the biological 
and social pre-disposition of younger women to infection (Dunkle et al., 2004, Leclerc-Madlala, 
2008). In the 2005 Human Sciences Research Council (HSRC) national household survey, one third 
of females reported to have had partners who were at least 5 years older than themselves (Shisana et 
al., 2005). Multiple partnerships and partner concurrency in South Africa are also considered 
significant factors in the transmission of HIV and other STIs (Johnson, 2007). In a recent household 
study of kwaZulu-Natal adults aged 15-49 years, 65% of men who had two or more partners in the 
past three years reported themselves to be in concurrent relationships, 19% reported concurrency in 
women who had two or more partners in the past three years (Harrison et al., 2008). A cross-
sectional survey of Khayelitsha residents in Cape Town reported that 29% of men and 8% of 
women had been involved in a sexual relationship outside of their current sexual partnership in the 
previous year. Men also reported that on average, their current partner was 4.4 years younger, while 
men over 40 years reported sexual partners who were on average 7 years younger than themselves 
(Boulle et al., 2008). Data from the 2003 South African Demographic Health Survey (SADHS) 
showed a linear relationship between an increase in the number of partners over the past year and 
increased level of education, among both men and women, thus suggesting that individuals with a 
higher education are more likely to be employed, and thus are at increased risk of HIV through a 











Condoms provide the most effective barrier method in HIV and STI prevention, however, 
evidence shows that condom use is predicted by many factors including age, sex, relationship status, 
exposure to media campaigns and cultural views (Katz, 2006, Katz and Low-Beer, 2008). While 
South African research has shown encouraging levels of condom awareness and accessibility, 
condom utilization has been reported to be insufficient to curb the spread of HIV (Hendriksen et 
al., 2007). In a nationally representative sample of South African youth conducted in 2007, the 
strongest predictor of condom use at last sex was whether or not respondents had used a condom at 
sexual debut. Other predictors of condom use at most recent sex included high condom use self-
efficacy, behaviour change related to increased HIV awareness, and optimism about the future. 
Decreased condom use at last sex was associated with marriage and relationships of more than 6 
months in duration (Hendriksen et al., 2007). The 2005 HSRC national household survey reported 
72% and 55% condom coverage in males and females aged between 15-24 years respectively. 
Among those reporting more than one concurrent partner, 60% of participants reported condom 
use at last sex (Shisana et al., 2005). In a household survey in Khayelitsha, Cape Town, 41% of male 
respondents and 33% of female respondents reported to have used a condom at last sex (Boulle et 
al., 2008). Qualitative studies in South Africa have documented barriers to consistent condom use, 
which include reported reduction in sexual pleasure, distrust in the efficacy of condoms and fear of 
potential side effects. Inconsistent barrier method use in this context has also been ascribed to 
cultural reasons, as well as the difficulties associated with condom use within long-term 
relationships; the subsequent implications on partner trust and the threat of derision by peers 
(Gibson and Nadasen, 2007, Versteeg and Murray, 2008). 
 South African research has also shown an association between disclosure status and sexual 
risk behaviour. In a study of HIV-infected women and men accessing HIV services, a high 
proportion stated that they were sexually active and 42% of these respondents stated that they had 
not disclosed their HIV status to a sexual partner in the past three months. Failure to disclose one‟s 
status was associated with an increased risk of multiple partner acquisition, as well as having an 
HIV-negative partner or a partner of unknown status (Simbayi et al., 2007). Another community 
survey of rural and urban HIV-infected South African respondents showed that disclosure was 
associated with reduction in multiple sexual partnerships and monogamy and an increase condom 
use (Wong et al., 2009). 
Sexual violence against women is also a risk factor for HIV transmission in South Africa. In a 
survey of men attending Cape Town STI services, those who had a history of sexual assault were 
more likely to have a history of multiple partners, genital ulcers and engaged in commercial sex 











well known. In Cape Town survey of STI clinic attendees, excessive alcohol use was associated with 
higher rates of sexual risk behaviour (Simbayi et al., 2004). High rates of unprotected sex (80%) with 
partners who were either HIV-negative or of unknown status were associated with moderate to high 
risk alcohol consumption in a sample of HIV-infected individual drawn from Cape Town HIV 
services (Kiene et al., 2008). 
2.4 Prevention of primary and secondary transmission of HIV 
Longstanding HIV primary prevention efforts in South Africa (as in other parts of the world) have 
mostly concentrated on structural and behavioural change. Structural approaches towards the social 
and economic empowerment of South African HIV-infected and non-infected women are ongoing 
and need further evaluation (Rao Gupta et al., 2008). Behavioural change programmes have used 
education and mass media to promote delayed sexual debut, decreased multiple sex partners, 
protected sex and HIV testing and continued adherence risk reduction behaviour (Coates et al., 
2008, Harrison et al., 2000). Evidence of success has been recorded by increased condom use among 
15-24 year old respondents in the HSRC national household surveys between 2002 and 2005. 
Trends in sexual partnerships and frequency of sexual intercourse, however, remained largely 
unchanged (Shisana et al., 2005).  
Most behavioural efforts are applicable to and have been effective in targeting secondary 
transmission among HIV-infected individuals f known serostatus. In particular, prevention 
campaigns have focused on the importance of HIV testing and safer sexual behaviour to limit 
secondary transmission. In the 2005 HSRC household survey, condom use with non-regular 
partners was higher among HIV-infected respondents than among those who were known to be 
seronegative. However, having multiple partners was associated with higher HIV prevalence and 
increased condom use and hence could be a potential confounder (Shisana et al., 2005).  
Recent prevention strategies have turned to biomedical and treatment intervention as a means 
of curbing both primary and secondary spread. Biological primary prevention strategies to date have 
included microbicide and vaccine research (Padian et al., 2008). Microbcides consist of a variety of 
antimicrobial agents to be used pre-coitally per vagina or rectum. Initially conceived as a female-
controlled intervention and then used in MSM, early research heralded microbicide interventions as 
promising, however, over the past decade, the results on the efficacy of microbicides in prevention 
trials have been discouraging (Padian et al., 2008). The spermicide, Nonoxynol-9, was shown to have 
no protective effect on HIV transmission in a multi-country trial among sex workers (Van Damme 
et al., 2002). Outcomes from the phase III trial of the entry/fusion inhibitor, Carraguard, showed no 











groups(Skoler-Karpoff et al., 2008). Current research is moving towards the use of ARV 
compounds; long-acting preparations and combination products (Padian et al., 2008). 
.Vaccine research for the prevention of HIV transmission has been unsuccessful to date, due 
to the genetic variability of HIV and its capacity to evade the neutralising antibodies contained in 
vaccines (Padian et al., 2008).  
Male circumcision is another approach which is being heralded as both a primary and 
secondary prevention strategy. The results of three recent clinical trials have demonstrated the 
protective effect of male circumcision on HIV transmission in men (Auvert et al., 2005, Bailey et al., 
2007, Gray et al., 2007). While male circumcision is protective for men due to cutaneous barrier 
change which reduces the risk of access to receptive cells for both HIV and other ulcerative STIs, 
the effect of male circumcision on HIV transmission in women and among MSM is not well 
understood. Furthermore this intervention has profound cultural implications in South Africa, and 
risks of complication which need to be considered before widespread implementation is feasible in 
local settings (Cohen, 2000, Titus and Moodley, 2008). 
Treatment strategies such as the syndromic management of STIs at public health facilities 
have had mixed successes. From the earliest research into South African high risk groups, a strong 
correlation between HIV and STI co-infection has been recorded (Williams and Gouws, 2001). 
While treatment protocols may explain declining trends in the prevalence of syphilis, drug shortages 
and heavy patient loads are reported to hamper coverage (Johnson, 2007). Yet, management of STIs 
on an individual and population level is complex. This is illustrated in well-documented evidence 
from three landmark intervention trials in Mwanza, Tanzania and Rakai, Uganda that showed the 
effect of sexual behaviour change on the effectiveness of STI treatment in the prevention of HIV 
(Grosskurth et al., 1995, Kamali et al., 2003, Wawer et al., 1999). These studies, which were 
conducted at radically different stages of the HIV epidemic, highlighted the importance of primary 
prevention intervention strategies to reduce sexual risk behaviour for concentrated epidemics and 
the need for different approaches, including increased VCT coverage; health education on treatment 
options for those infected and a focus on prevention in stable partnerships, to prevent secondary 
transmission in generalized epidemics where behaviour change had already occurred or was 
occurring (Korenromp et al., 2005).  
Hence an understanding of the evolution of transmission dynamics and sexual risk behaviour 
and temporal effects on epidemic stages has been shown to be crucial in the planning and timing of 
HIV prevention interventions. More recently in the face of generalized epidemics, prevention 
programmes have shifted focus away from primary prevention in uninfected high risk groups, to 











seropositive status and their partners who either are not infected, or are of unknown status. The 
motivation for moving from protecting individuals from acquiring HIV to incorporating the 
prevention of transmission from infected individuals has largely stemmed from the advent of 
antiretroviral therapy (ART) and the clinical evidence of its benefits. Since individuals who are on 
ART are living longer and healthier lives, so prevention efforts which focus on their sexual health 
and behaviour have been recognised as important (Coates et al., 2008, Elford, 2006). 
2.5 Changing patterns of sexual risk behaviour in the era of antiretroviral therapy 
Advances in treatment in the era of ART have resulted in dramatic clinical benefits and improved 
patient outcomes in settings with universal access to treatment (Quinn, 2008). AIDS mortality has 
declined in settings where ART has been made widely available and treatment has been associated 
with significant decreases in log viral load, improved survival and enhanceme t of quality of life 
(Kravcik et al., 1998). Mathematical models of the impact of ART have shown significant reduction 
in HIV incidence up to 50% over 10 years in best-case scenario simulations where widespread 
treatment was rapidly initiated in early disease stage by all HIV-infected individuals (Garnett et al., 
2002). Simulation of the South African epidemic, where treatment initiation criteria dictate that only 
a small proportion of infected individuals receive ART, predicts little direct impact of ART on HIV 
incidence but a significant increase in the HIV prevalence pool over time due to the prolongation of 
life (Johnson and Dorrington, 2006). 
2.5.1 Health-related quality of life 
With HIV increasingly being perceived as a manageable chronic disease, so an interest in the health-
related quality of life (HRQL) of HIV-infected individuals has been cultivated. HRQL covers a 
broad range of physical a d psychological characteristics which dictate an individual‟s capacity for 
daily functioning and satisfaction in the context of a particular health state being experienced (Tsasis, 
2000). Specific measures of HRQL which incorporate a spectrum of mental, physical, functional and 
social domains have been developed, validated and applied to HIV-related studies across settings 
(Clayson et al., 2006, Huang et al., 2008). Prospective studies have focused on the long term benefits 
of ART, while cross-sectional studies have compared the HRQL of individuals on ART to those not 
on ART in the same setting. Other studies have compared HRQL differentials across gender and 
other vulnerable groups with the aim providing improved treatment and care services (Rao et al., 
2007). While it has been found that lower scores of HRQL are recorded among HIV-infected 
individuals than in the general population, ART has the potential to improve these scores within the 











The long term benefits of ART have been documented in Europe in a 5-year follow up study 
of a French cohort on treatment confirmed previous findings of improved HRQL within the first 
six months to a year of treatment initiation. A lower CD4 cell count was associated with initial lower 
physical and mental scores, possibly due to faster disease progression among these individuals. The 
study showed that these scores improved over time, demonstrating the efficacy of ART. 
Furthermore, treatment side effects were associated with impaired daily functioning. However, 
adaptation to the side effects of treatment over time led to improved scores. Socio-demographic 
factors positively associated with better mental and physical well-being included being younger and 
having no children to look after. Also, improved mental health was associated with being male, 
MSM, and having a stable partner and self report of fewer physical and metabolic symptoms of 
illness, for example, lipodystrophy (Protopopescu et al., 2007).  
Two studies in the Free State province and one study in the Western Cape, South Africa have 
reported improved HRQL measures in patients within the first year of treatment initiation 
(Louwagie et al., 2007, Wouters et al., 2007). Modelled data from a longitudinal study of patients 
enrolled with at least two months treatment experience, predicted that improvements in physical 
HRQL were positively associated with being male, higher education and initial months of ART 
treatment. A positive association between improved emotional HRQL and being on treatment was 
also observed. Patients receiving treatment also reported significantly higher levels of emotional 
HRQL than those still awaiting treatment. Physical improvements in HRQL were seen to mediate 
the association between emotional well-being and treatment status (Wouters et al., 2007). A cross-
sectional study of patients waiting to initiate ART and patients who had been on ART for under 90 
days, sampled from the same patient population that used by Wouters et al, showed respondents on 
ART were significantly less likely than those awaiting ART to report high problem scores on all the 
domains of the HRQL measure. Interestingly, being female and being employed were independent 
positive predictors of higher self reporting of HRQL scores (Louwagie et al., 2007). In a different 
study, in Cape Town (Jelsma et al 2005b), patients receiving treatment for 12 months in three public 
sector clinics, also showed linear improvements in their health states over time, with self-reported 
well-being scores contributing to 50% of total improvement in the first month of treatment 
initiation (Jelsma et al., 2005b).  
Scant evidence exists on the association between HRQL and the sexual health and activity of 
HIV-infected individuals, either on treatment or not. A nationally representative study of French 
men and women with HIV showed that sexual difficulty was associated with lower levels of sexual 
activity. Furthermore, both HIV-related symptoms, as well as HIV treatment were associated with 











2.5.2 Voluntary counselling and testing 
The advent of ART, its perceived benefits and efforts to extend universal access to treatment, has 
resulted in increasing numbers of people accessing HIV testing and care (UNAIDS, 2008). Hence 
this is seen as an opportunity to intensify secondary prevention efforts through increasing the 
proportion of infected individuals with known - as opposed to unknown - positive serostatus at 
population level. Some research has shown a link between certain measures of risk reduction post-
HIV testing among HIV-infected and HIV-uninfected individuals. In a meta-analysis of studies of 
the effect of VCT in developing countries between 1990 and 2005 (Denison et al., 2008), a 
significant association between recent VCT and a decrease in unprotected sex when compared to 
behaviour prior to testing, or to respondents who had not undergone VCT. In this meta-analysis, 
however, VCT had no significant impact on number of sexual partners post-counselling and testing 
(Denison et al., 2008). 
In another study of 66 newly-infected MSM from seven cities in the United States, reduction 
in unprotected anal intercourse (UAI) was evident after receipt of diagnosis, however, these 
individuals were not seen to engage in lower risk sexual behaviour in the 12 months of follow up 
post diagnosis, indicating a reduction of frequency, but not degree of risk in sexual behaviour 
(Coldfax et al., 2002). A meta-analysis of studies in American settings examined the sexual risk 
behaviour among HIV-infected individuals who knew their status and others who did not know 
their status. In a pooled analysis of 11 studies, the prevalence of unprotected anal or vaginal 
intercourse was significantly less among HIV-infected individuals who were aware of their 
seropositive status than in HIV-infected individuals who were not aware of their seropositive status, 
with a combined effect size across all studies being a 53% reduced risk of sexual risk behaviour in 
those aware of their seropositive status (Marks et al., 2005).  
Evidence from developing contexts is sparse. In a cohort study of Zimbabwean men and 
women, VCT uptake was associated with a significant reduction (approximately half) in the number 
of partners in the past year in HIV-infected respondents. At one year follow up, consistent condom 
use over the previous two weeks was significantly associated with VCT in HIV-infected women in 
this study (Sherr et al., 2007). 
A South African cross-sectional study of HIV-infected respondents of known positive 
serostatus attending HIV care services, suggested significant differences between urban and rural 
residents regarding sexual risk behaviour. Urban residents were more likely to be currently sexually 
active (OR: 2.9, p=0.001) and to be in regular sexual partnerships (OR: 3.53, p<0.001) than their 
rural counterparts. Urban residents were more likely to report consistent condom use with both 











counterparts, suggesting the importance of targeting prevention efforts in rural areas in South Africa 
(Lurie et al., 2008). 
2.5.3 Treatment optimism 
Concerns about the unintended effects of treatment on elevated sexual risk behaviour in HIV-
infected individuals have been tested in observational research. Such studies were based on the 
assumption that community perceptions of reduced infectiousness and improved survival associated 
with treatment efficacy, would lead to increased levels of sexual risk behaviour among high risk 
groups regardless of sero- or treatment status. This phenomenon is denoted in the literature as 
„behavioural disinhibition‟ or „treatment optimism‟ (Crepaz et al., 2004b).  
2.5.4 Developed country research 
Early studies of treatment optimism which were carried out in developed contexts with well-
functioning ART treatment and care services, largely focused on sub-populations of seropositive 
and seronegative MSM, and produced conflicting results. For example, a study of American male 
and female clinic attendees accessing ART, demonstrated a significant association between 
optimistic treatment-related beliefs and unprotected sex in non-concordant partnerships. Findings 
from this study suggested that perceptions of the preventative efficacy of ART existed regardless of 
log viral load among discordant couples (Kalichman et al., 2006). Furthermore, a longitudinal study 
(1999-2002) of Dutch seronegative MSM practicing regular high risk sexual behaviour found a 
significant association between the beliefs in reduced threat of HIV/AIDS since the advent of ART 
and changes from protected to unprotected receptive anal intercourse (Stolte et al., 2004). However, 
a series of cross-sectional studies between 1998-2001 of MSM attending London gymnasiums and of 
mixed and unknown HIV serostatus, found no association between increased rates of high risk 
sexual behaviour and treatment optimism, and no differences in sexual behaviour were detected 
among men who were optimistic about ART and men who were not optimistic about ART, over 
time (Elford et al., 2002) 
Another cross sectional study of HIV-infected MSM attending an outpatient clinic examined 
rates of high risk sexual behaviour between respondents on ART and respondents not on ART. In 
crude analyses, men on ART reported significantly fewer new partners in the previous year than men 
not on ART and lower frequency of UAI with 1 or more partners in the previous year than men not 
on ART. These results suggested that while high risk sexual behaviour was still prevalent among 
HIV-infected individuals, frequency and level of risk behaviour was less among those on ART 











A meta-analysis of 21 studies undertaken in Europe and the United States that examined the 
association between unprotected sexual intercourse or STIs as a proxy for sexual risk behaviour and 
being on ART, showed no significant difference in sexual risk behaviour between HIV-infected 
individuals on ART and those not on ART . However, an interesting finding in this review, which 
incorporated a further 11 studies (including the abovementioned two studies on treatment 
optimism) on attitudes of HIV-infected and HIV-negative individuals, was a significant positive 
association between elevated sexual risk behaviour and beliefs held by infected and uninfected 
individuals alike, that treatment and decreased viral load was protective against HIV transmission 
(Crepaz et al., 2004a). 
A more recent study in France concurs with the above evidence that treatment is not 
associated with elevated sexual risk behaviour in HIV-infected individuals. In a study of heterosexual 
sero-discordant couples, risky sexual behaviour was associated with duration of relationship, being 
under the age of 40 years, financial difficulty and excessive alcohol consumption in men. A history 
of substance use, financial difficulty and lack of awareness of a partner‟s serostatus and difficulty in 
negotiating condom use was significantly linked to increased sexual risk behaviour in women. Of the 
participants, 80% were on ART, while 69% had an undetectable viral load, however, neither of these 
variables was associated with sexual risk behaviour (Bouhnik et al., 2007).  
2.5.5 Developing country research 
Evidence on the association between sexual risk behaviour and treatment from developing country 
settings is limited, due to ART programmes being still in their infancy; the different transmission 
dynamics of HIV operating within mature epidemics, which require specific programmatic 
prevention and control measures, and a lack of widespread access to antiretroviral treatment for 
those in need (Kennedy et al., 2007, Salomon and Hogan, 2008). In a multi-centre cross-sectional 
study of Brazilian HIV-infected men attending HIV care who engaged in high risk anal or vaginal 
sexual activity, showed in univariate analyses that not being on ART was associated with 
inconsistent condom use in the previous year, however, this finding was statistically insignificant 
(OR: 1.6, 95% CI: 0.9-2.1). In this study setting drug use, having stable partners, the number of 
female partners and having an STI were significant correlates of unsafe sexual behaviour (Guimaraes 
et al., 2008).Evidence from research into sexual risk behaviour and secondary transmission of HIV 
is beginning to emerge from settings in Africa. A systematic review of the impact of HIV treatment 
on sexual risk behaviour by Kennedy et al (2007) reported three African studies which indicated 
significant reductions in sexual risk behaviour in HIV-infected individuals on ART (Kennedy et al., 
2007). First, in a cross-sectional survey of 711 HIV-infected individuals attending services in two 











with high levels of abstinence. Frequency of sexual activity was higher among men than among 
women; and not being on ART was significantly related to higher levels of risky sexual activity 
among those who were sexually active. Respondents on ART were approximately half as likely to 
engage in sexual risk behaviour as those who were not on ART (OR: 0.52, 95%CI: 0.29-0.93). In 
bivariate analyses, a significantly higher proportion of untreated HIV-infected respondents had 
engaged in casual sexual intercourse at their last sexual act (no OR specified, p=0.02) and 
significantly fewer respondents on ART had unprotected sexual intercourse at last sexual act (no OR 
specified, p=0.001). The authors argue that the reason for these results could be attributable to the 
increased promotion of safer sexual behaviour practices which offered by health care staff to those 
accessing ART. Furthermore, the study was carried out within 18 months of treatment roll out, 
hence it is possible that the results reflect only the short term impact of ART and treatment care on 
sexual risk behaviour (Moatti et al., 2003). 
Second, a cross-sectional survey of HIV care among male and female attendees at a clinic in 
Kampala, Uganda showed no association between increased sexual activity and being on treatment, 
but rather significant reductions in some sexual risk behaviours among those on ART, compared to 
those not on ART. For married respondents, ART-treated attendees were more likely to have 
disclosed their serostatus to a spouse than treatment naïve respondents (OR: 1.57, 95% CI: 1.07-
2.30). While rates of consistent condom use were high overall among respondents for spouse, 
regular and commercial partners, respondents on ART reported significantly higher rates of 
consistent condom use in spousal relationships than respondents not on ART (OR: 2.82, 95% CI: 
1.74-4.6). ART-treated respondents were significantly more likely to report condom use at last sexual 
intercourse with a regular partner than respondents not on ART. Respondents on ART were 
significantly more likely to report with an STI than non-ART respondents (Adjusted OR: 2.6, 95% 
CI: 1.77-3.82), however, this result could be due to increased opportunity and methods for diagnosis 
and treatment through regular contact with ART services. While over half of the sample was not 
sexually active, ART-treated respondents were more likely to be sexually active (OR: 1.35, 95% CI: 
0.99-1.82), however, overall this study did not find an association between ART treatment and risky 
sexual behaviour in the previous 6 months. This study measured physical attributes of HRQL, and 
found that ART-treated respondents reported significantly higher physical well-being after a mean 
treatment duration of 1.6 years, than ART-naïve respondents (p>0.0001) (Bateganya et al., 2005). 
A third study in rural Uganda showed promising reductions in sexual risk activity among 
patients on ART. A prospective cohort of HIV-infected adults with advanced stage disease, was 
followed up after 6 months experience of a home-based ART treatment programme. Sexual 











the previous 3 months. Of those who were in stable partnerships, 65% of men and 59% of women 
reported being sexually active in the past 3 months. Of those who were not in stable partnerships, 
13% of men and 9% of women reported sexual intercourse in the past 3 months. Among all the 
sexually active respondents, 44% of men and 45% of women reported unprotected sex with at least 
one partner. While the percentage of respondents who had been sexually active at baseline did not 
change significantly among men (p=0.2243) or women (p=0.1772) at follow up, significant 
decreases in unprotected sex (AOR: 0.5, 95% CI: 0.3-0.8) and unprotected sex with a negative or 
unknown partner (AOR: 0.4, 95% CI: 0.2-0.6) were noted among all respondents. Within stable 
partnerships, increases in consistent condom use with partners of negative or unknown status 
(p=0.0003), as well as an increase in condom use within concordant partnerships (AOR: 2.2, 95% 
CI: 1.4-3.7). Investigators found that over 85% of reported sexual risk behaviour occurred between 
married and cohabiting couples, however, overall sexual activity was low from baseline. It is unclear 
as to the effect prevention activities which were a mandatory part of the study, as well as self-
reporting bias may have had on these promising results of risk reduction in ART-initiated 
respondents (Bunnell et al., 2006). 
Contrary to these results, another recent prospective study of treated and untreated HAART 
patients enrolled in HIV care services, Côte d‟Ivoire, showed an increase in sexual risk behaviour at 
6 month follow in the treatment group. Interestingly, at baseline, those who did not receive ART 
reported higher rates of unprotected sexual intercourse compared to those who started treatment 
(RR: 1.25, 95% CI: 1.05-1.49). Significant increases in unprotected sexual intercourse in the 
treatment group by 6 months follow up (RR: 1.40, 95% CI: 1.21-1.61) and stability among the 
untreated group (RR: 1.07, 95% CI: 0.94-1.20) suggests strong association between ART treatment 
and increase in sexual risk. However, investigators maintain that this sexual risk was contained in 
stable partnerships, and the median number of partners did not increase over time. This has specific 
implications for secondary transmission within discordant stable partnerships (Diabate et al., 2008). 
Another prospective study in Kenya, however, showed a decrease in sexual risk behaviour in a 
cohort of clinic attendees at 12 month post-ART initiation follow up. At baseline, approximately 
half the sample was sexually active, and half of these respondents reported engaging in unsafe sex. 
After twelve months of treatment, 28% of those who reported sexual activity were practicing risky 
sexual behaviour. Unsafe sex was associated with non-disclosure, recent diagnosis, not being in a 
cohabitational relationship or marriage, and stigma, depression and a body mass index <18.5kg/m2 
(Luchters et al., 2008). 
The mixed results of the studies conducted in African contexts do not indicate consistent 











of sexual risk behaviour and transmission dynamics across contexts. Furthermore, these results 
imply the need for country-specific prevention programmes.  
In conclusion, the field of secondary prevention of HIV in light of sexual risk behaviour in 
South Africa is under-researched. While there is some evidence indicating the positive HRQL 
outcomes on South African HIV-infected individuals accessing ART treatment, little is known about 
their sexual risk behaviour. Baseline data for a prospective cohort study of attendees not on 
treatment and recently initiating treatment at Cape Town public sector HIV services, showed no 
significant differences in reported condom use nor number and type of sexual partnerships in the 
past month in bivariate analyses of treatment status. Levels of sexual behaviour in the past month 
were high, with 59.7% of men and 62.3% of women reporting to have had at least one sexual 
partner (Eisele et al., 2008). Taking into account the variation in results found in studies both in 
developed and developing country settings discussed above, extrapolation to local context is 
problematic, and further context-specific research is required to understand and inform secondary 













3 METHODS  
3.1 Study setting 
This analysis constitutes a sub-section of a broader study of the fertility intentions, contraceptive 
service needs and reproductive decision-making behaviour of HIV-infected women and men in 
Cape Town, South Africa. The objectives of the main study were to inform health service 
improvement for HIV-infected individuals by exploring fertility intentions, contraceptive choices 
and reproductive decision-making among these individuals, their partners and their communities. 
Furthermore, the main study explored health care provider attitudes towards the reproductive 
choices of HIV-infected individuals (Cooper et al., 2007, Harries et al., 2007, Orner et al., 2008). The 
study employed quantitative and qualitative methodology: 8 focus group discussions were held with 
HIV-positive men and women respectively; 4 in-depth interviews were held with HIV-infected men 
to explore treatment and care issues. A further 26 in-depth interviews were conducted among health 
care providers and health care managers and a quantitative cross-sectional survey was undertaken 
comprising 459 respondents. This mini-dissertation focuses exclusively on the analysis of variables 
of the cross-sectional survey, the methodology of which is described below. 
Fieldwork was conducted at two public sector health facilities in the peri-urban community of 
Gugulethu, 18 km outside Cape Town. The suburban population was estimated to be 170 552 in the 
2001 South African Census (Provincial Administration of the Western Cape, 2006). Formal and 
informal housing is relatively equally proportioned in this suburb, with 42% of dwellings being brick 
structures on separate stands (Provincial Administration of the Western Cape, 2006). 
Two research sites, Gugulethu Day Hospital and Hannan Crusaid ARV Centre were selected 
for the study, each being primary-level facilities which together offer a range of healthcare services. 
Gugulethu Day Hospital offers curative and chronic services, as well as HIV testing for clinic 
attendees. The facility does not operate an antenatal or obstetric service, but the Gugulethu Midwife 
Obstetric Unit (MOU) is available to pregnant women on the same premises. This unit offers 
antenatal services 5 days per week and a 24 hour labour ward service. Women are offered VCT in 
pregnancy, and if found to be HIV-positive, they are offered PMTCT services. Furthermore, HIV-
infected patients who are eligible for ART initiation (CD4 count ≤ 200 cells/µl) are referred from 
both the CHC and the MOU to Hannan Crusaid ARV Centre which operates as a separate facility 
on the same premises. 
Ethical approval for the study was obtained from the University of Cape Town Research 











Approval was obtained from local government health directorates for the use of Gugulethu Day 
Hospital and Hannan Crusaid ARV Centre. 
Awareness of the sensitive nature of the research – notably the sexual behaviour and 
reproductive intentions of HIV-infected individuals – was taken into account, and all interviewers 
received thorough training in interviewing techniques, sexual and reproductive health issues and 
research sensitivity. Interviewers were available to all respondents for the duration of the fieldwork, 
and were obliged to assist in the referral of respondents to appropriate sources of clinical or 
psychological support upon request. 
Written informed consent was obtained from each respondent prior to the interview. The 
consent document outlined the nature of the research, its purpose and the procedures involved, as 
well as the expected duration of the interview and potential risks and benefits of participation. 
Respondents were recruited without duress or undue influence. Compensation for cost of travel and 
light refreshments were offered for the time given for the interview.  
The voluntary nature of respondent involvement, as well as the freedom to withdraw from the 
interview without prejudice was outlined in the informed consent procedure. Participant 
confidentiality was upheld through anonymous interviewing practices. No names were recorded 
during the interview process. 
Participating in the questionnaire involved little risk to the respondent, due to the stringent 
adherence to ethical procedures for this research. While there was no direct benefit for involvement 
in the study, respondents contributed to the greater societal good: by sharing their experiences of 
and attitudes towards sexual behaviour in the context of HIV-infection, the collection of such data 
would serve to directly impact on the improvement of future health services for HIV-infected 
individuals as well as to inform prevention efforts against the secondary transmission of HIV. 
3.2 Study population 
The study population constituted all HIV-infected adults attending HIV-related services and 
Gugulethu Day Hospital (including the Gugulethu MOU) and Hannan Crusaid ARV Centre. Sample 
size calculation for PMTCT and VCT care respectively was based on an estimation that 2 000 men 
and women enrolled for each of these services annually. Since the primary focus of the study was to 
ascertain fertility intentions of HIV-infected individuals, the sample from PMTCT and VCT care 
was drawn based on the assumption that at least 50% of these clinic attendees would be sexually 
active but not be planning future children. A 10% margin of error, plus a further 10% over-sampling 











from VCT and PMTCT services respectively, and 150 men and women from HIV care and ART 
services respectively (n=470). 
3.3 Sampling 
Systematic random sampling methods from the daily clinic registers ensured that the sample selected 
was representative of clinic attendees seeking PMTCT, VCT and HIV or ART care at each site. A 
total of 174 (38%) male and 285 (62%) female attendees (n=459) aged between 18 and 68 years were 
randomly selected from Gugulethu Day Hospital and MOU, and Hannan Crusaid. During each day 
of recruitment, fieldworkers generated a random number sequence to select patients from the daily 
list of attendees on the clinic registers for each service. From the HIV service, 6 men and 6 women 
were randomly selected every day. Over-sampling was applied to this service in order to attain the 
sample of ART patients, because no distinction was made in the register between those who were 
on treatment and those who were not. From the PMTCT service at the Gugulethu MOU, 4 post-
partum women were randomly selected from the register of women waiting to attend the service on 
that day. Similarly for the VCT sample, 4 men and 4 women who were waiting for their HIV test 
results were randomly selected from the VCT register on the day.  
Men and women attending the selected study sites were eligible for participation if they were 
18 years or older and reported themselves to be HIV-infected. Respondents also had to be willing to 
have basic medical information extracted from their patient folder and agree to share with the 
interviewer certain aspects of HIV infection as per the questionnaire. Written informed consent for 
the use and sharing of this information was obtained from each participant prior to commencement 
of the interview.  
Refusal to participate in the study was recorded for those who either declined the offer of 
participation extended by the clinic staff or for those who refused an interview upon meeting the 
interviewer, once the interviewer had imparted more information about the study. The age, sex and 
service attended of each refusal were collected in order to inform the assessment of non-response 
bias. The response rate was 93%. Of the 489 candidates approached, 459 of these provided 
informed consent and successfully completed the interview. In total, 30 (7%) of respondents 
declined the interview, on grounds of either being too ill or being time constrained. A total of 459 
interviews were retained for subsequent analysis.  
Respondents were recruited between May and September 2006. All interviews were face-to-
face and conducted by four trained field work staff, each of whom had previous experience in 











of the respondent (isiXhosa), in a private room provided by the respective health care sites. 
Respondents were reimbursed for transport costs. 
3.4 Measurement 
A standardized interviewer-administered structured questionnaire was used. The response format 
comprised a combination of closed and open questions. Each closed question yielded mutually 
exclusive, dichotomized or multi-item response categories. Categories were scaled and numerically 
pre-coded. In order to anticipate unknown responses, an „other‟ category was assigned in some 
questions where appropriate. Open questions were included for probing purposes to enrich the 
content of certain closed questions pertaining to attitudes and beliefs.  
The questionnaire was translated into isiXhosa and back-translated into English to ensure 
thematic coherence. A small pilot study was conducted to assess the instrument‟s sensitivity and 
appropriateness to content and adequacy of field worker training, as well as to pre-empt design 
failure. 
Interviews were conducted in the clinic by trained field workers. For each interview, randomly 
selected candidates were approached by the health care provider or counsellor immediately after the 
consultation. Information about the study was given by the clinic staff before candidates were asked 
whether they were prepared to participate. Upon agreement, respondents were led to a private room 
to meet the interviewer, and an interview was either conducted immediately or scheduled for a time 
convenient to the respondent. 
The instrument included questions arising from the following six themes: 
3.4.1 Measurement of socio-demographic characteristics  
Socio-economic data were collected on participants, including age, sex, level of education attained 
and employment status, income, housing type and household size and parity.  
3.4.2 Measurement of sexual risk behaviour 
Sexual risk behaviour was measured by determining intimate partnerships and sexual activity among 
participants. Sexual activity was defined as penetrative vaginal or anal intercourse. Participants were 
defined as being sexually active if they had engaged in sexual activity in the past month. Descriptions 
of current sexual relationships where applicable, number of sexual partners in the last 6 months, 
frequency of sexual intercourse in the past month and condom use in the past six months was 
collected. Furthermore, data on self-reported sexual activity and number of sexual partners were 











3.4.3 Measurement of HIV infection and antiretroviral treatment status 
The instrument collected data on time since HIV diagnosis, current ARV treatment use, and the 
duration on treatment.  
3.4.4 Contraception and dual method use 
Contraception and dual method use assessed such use before and after HIV diagnosis and after 
ART initiation. 
3.4.5 Health status and health-related quality of life 
Measures of health status included self-reported descriptions of clinical disease staging and CD4 cell 
count. To measure a subjective response to health-related quality of life, two measures were used. 
First, a visual analogue scale (VAS) was incorporated as a self-rating measure of health status. This 
psychometric measure was based on the Euro-Qual visual analogue scale (EQ VAS) (The EuroQol 
Group, 1990). The EQ VAS constitutes a part of a standardized measure of health status, the EQ-
5D, which was developed by the EuroQoL Group, and has been validated in many settings, 
including South Africa. The EQ VAS scale is calibrated from 0 to 100, where 0 represents the worst 
and 100 represents the best imagined self-rated health st tus score. Individuals are asked by the 
interviewer to rate their health status on the day of the interview, and the results of this measure are 
used as an evaluation of the participant‟s overall health status (Oppe et al., 2007). 
Second, an adapted, unofficial version of the EQ-5D descriptive system (The EuroQol 
Group, 1990), a five-dimension measure a respondent‟s subjective health state was used. Four of the 
original five dimensions of this measure were incorporated in the questionnaire, and comprised 
three self-rated levels (no problems, some problems, extreme problems) on the dimensions of pain 
and/or discomfort; usual activities; mobility and anxiety and/or depression respectively. 
3.4.6 Psycho-social impact of HIV-infection 
Data were gathered on participant disclosure status, their experiences of stigma and the perceived 
reactions of others to their HIV-positive status.  
3.5 Data management and quality control 
All completed questionnaires were checked on a daily basis by the study co-ordinator. Queries and 
errors were clarified by the field workers within 2 days of the interview date.  
A customized template was designed in Microsoft Access 2000, and data were captured by 











used in the data capture process. Data were transferred to STATA Release 10 (STATACorp, College 
Station, USA). Internal logic checks and frequency distributions were generated to identify 
problematic observations. Data queries were resolved against the original questionnaires. After 
completion of data capture and quality control, all questionnaires were stored in a secure file to 
protect respondent confidentiality. 
3.6 Variables 
3.6.1 Outcome variables: sexual risk behaviour 
Sexual risk behaviour was defined by and assessed with three outcome variables: sexual activity in 
the past month; number of sexual partners in the past 6 months; and condom use at last sexual 
intercourse. 
Sexual activity in the past month 
First, sexual activity in the past month was deemed a useful proxy for being sexually active given the 
data to hand. Respondents were asked to respond to the following question, “Approximately how 
many times have you had sexual intercourse in the past month?” Observations that were missing 
were not included in the subsequent analyses (n=33). A binary variable was created from this 
question, this variable being divided into “No sexual intercourse in the past month” and “Any sexual 
intercourse in the past month”. 
Number of sexual partners in past 6 months 
Second, sexual risk behaviour was measured in terms of multiple sexual partnerships, not restricting 
the analysis to only those who reported being sexually active in the past month. Respondents were 
asked the following question, “Approximately how many sexual partners have you had in the past 
six months?” Observations that were missing were excluded from subsequent analyses (n=4). The 
data were then coded to create a binary variable: “Low risk sexual behaviour” (None or one sexual 
partner in the past six months) and “High risk sexual behaviour” (more than one sexual partner in 
the past six months). Concurrent sexual partnerships were not examined in this study, as provision 
for such measurement had not been made in the instrument. 
Condom use at last sexual intercourse 
Sexual risk behaviour was measured by looking at the reported use of a barrier method (either a 
male and/or female condom) at last sexual intercourse among respondents who reported to be 
sexually active in the past month. Respondents were asked the following question, “When you last 
had sexual intercourse, did you use a male or female condom?” The data were collected as a four 
level variable where levels 1 and 2 pertained to male and female condom use respectively, level 3 











sexual intercourse. A binary yes/no variable was created by grouping the first three levels together as 
condom use at last sexual intercourse, versus no condom use at last sexual intercourse. 
3.6.2 Explanatory variables 
Demographic and socio-economic status variables 
The questionnaire covered items on respondent age, sex and home language. Age was collected as a 
continuous variable, and a categorical variable was created on three levels, notably participants under 
25 years, 25-35 years and 35 years and older . Home language consisted of five categories: isiXhosa, 
isiZulu, Afrikaans and English, plus a category for other languages specified by the respondent. 
Since the home language of respondents was overwhelmingly isiXhosa, this variable was not 
included in the analysis. 
Socio-economic status was investigated using type of residence, respondent employment 
status, monthly income and level of respondent education. Residence type was dichotomized into 
informal and formal housing status. Similarly, a dichotomous variable was created for employment 
status to represent those who were unemployed, versus those who were either employed or 
studying. A three-level variable for household monthly income (in current South African Rand) was 
created to include the following: under R1 000; R1 000 – R2 999 and R3 000 – R7 999. Educational 
level attained was described as a dichotomous variable (“Primary level education or less” and 
“Secondary level education or more”).  
Sexual activity 
Variables describing sexual activity, which were supportive of the sexual risk behaviour outcome 
variables, included current sexual relationship status and duration of current sexual relationship.  
A three-level variable was formed to describe current sexual relationship status from two 
existing variables in the dataset. The existing variables constituted a dichotomous variable describing 
whether or not the respondent was in a current sexual relationship, and a multiple-level variable that 
described the type of relationship which the respondent reported (married; unmarried but co-
habiting; in a relationship but not co-habiting). The new variable described the following three 
categories: not in a relationship; in a non-cohabiting relationship and in a co-habiting relationship 
(including the assumption that married couples co-habited).  
Similarly, a three-level variable was created to describe current sexual relationship duration. In 
this variable, observations who reported not to be in a relationship were included in order to 
maximize and retain the sample size in the multivariate regression analyses. Categories were thus: 












Respondents in a current sexual relationship were asked whether their partner had parented a 
child with them. A dichotomous “yes/no” variable was created out of the question, “Is your current 
partner the parent of any of your children?” Observations which recorded “Not applicable” due to 
not having offspring, were dropped. 
Respondents were asked to recall how frequently they had used a barrier method (male or 
female condom) over the past six months. Responses were coded into six categories, notably 
“Always”; “Most times”, “Sometimes”; “Rarely”, “Never” and “Not applicable”. These categories 
were collapsed to form a new dichotomous variable describing “consistent condom use” (denoting 
100% use) and “inconsistent condom use” (denoting less than 100% use) in participants declared to 
be sexually active in the last six months. Sexually abstinent observations that fell into the “Not 
applicable” category were dropped from this variable. 
A question to ascertain the frequency of sexual intercourse after HIV diagnosis was asked. 
Respondents were requested to recall and compare whether they had sexual intercourse “more 
frequently”; “less frequently”; “as frequently” as pre-HIV diagnosis, or whether they had ceased to 
be sexually active since diagnosis. A new variable was coded for three levels to denote sexual 
intercourse since HIV diagnosis as “more frequent”; “about as frequent” and “less often or 
abstinent”.  
Similarly, participants who were on ART were asked to recall and compare whether they had 
sexual intercourse “more frequently”; “less frequently”; “as frequently” since ART initiation, or 
whether they had ceased to be sexually active since HIV diagnosis. A three-category variable was 
developed to describe responses to frequency of sexual intercourse since ART initiation as “more 
frequent”; “about as frequent” and “less often since initiation or abstinent since HIV diagnosis”. 
Respondents were asked to report numbers of sexual partners acquired since HIV diagnosis. 
A new dichotomous variable was formed to group reported sexual partner counts into “0 -1 
partner” and “two or more partners”. Similarly, another dichotomous variable was developed to 
categorize counts of sexual partners since ART initiation, each level denoting “0-1 partner” and 
“two or more” partners post-ART initiation. 
Health status and treatment status 
Three variables measured self-reported health status in relation to HIV. Respondents were asked to 
report time since HIV diagnosis in years and months. From this data, a variable for time since HIV 
diagnosis was created in months. This variable was dichotomised to denote those who had been 
diagnosed <12 months prior to the survey and those who had been diagnosed ≥ 12 months prior to 
the survey. In addition, respondents were asked to report their most recent CD4 cell count and 











cells/µl or less; 350 cells/µl or less or more than 350 cells/µl. Data that were coded as “Missing” or 
“Don‟t know” were recoded as missing (n=85 (18.5%)). Similarly, a four-level variable was created 
to describe the four WHO stages. Data that were coded as “Missing” (n=163) or “Don‟t know” 
(n=98) were recoded as missing (n=261 (56.8%)). 
Disclosure status 
Respondents were asked about HIV disclosure status by answering seven disclosure options with 
yes/no answers. The options were not mutually exclusive and included disclosure to partner(s); 
family member(s); household members other than family; friends; other community members and 
health care providers other than those involved in HIV treatment and care. A summarized 
dichotomous variable describing disclosure status was developed from these seven categories, 
denoting two mutually exclusive categories: disclosed no-one or disclosed to someone. The sample 
size was too small to create categories that distinguished between partner disclosure and disclosure 
to individuals other than a partner. 
Dual method use 
Respondents were asked to recall their use of barrier and non-barrier contraceptive methods both 
before and after HIV diagnosis. Respondents on ART were asked to describe their contraceptive 
method usage after they had initiated treatment. All respondents were requested to describe which 
contraceptive methods they were currently using. Twelve separate variables were created to cover 
methods, which included modern methods such as the oral contraceptive pill (OC); two- or three-
month injectable; intrauterine contraceptive device (IUD), female or male sterilization; male or 
female condom or the diaphragm. Recall of no method was also measured in this question. The use 
of twelve variables allowed for dual method use (the use of a contraceptive method in parallel with a 
barrier method, such as a male or female condom). 
These variables were recoded to provide three composite dichotomous variables that 
described dual method use (yes/no) pre- and post-HIV diagnosis; dual method use among those on 
ART, and current dual method use. 
 Health-related quality of life 
Respondents were asked to rate their level of pain and/or discomfort; ability to perform usual 
activities; mobility and anxiety and/or depression respectively. A three-level index score was 
developed for each of these four health states as follows, where the reference item denoted “No 
problems”, the second item denoted “Some problems” and the third item denoted “Severe 
problems”.  
The EQ VAS scale consisting of self-reported health state scores between 0 and 100, was re-











HRQL three-level variables mentioned above, to produce a composite measure of HRQL, which 
had a range between 0 and 12. This composite scale was then divided into tertiles, to assist with ease 
of interpretation. 
3.7 Response Rate 
The response rate for socio-demographic and socio-economic items was high, with data being 
almost entirely complete. The response rate for data collected on the following variables rendered 
them sub-optimal for multivariate analyses, yet useful for descriptive measures and bivariate 
analyses: parenting within sexual partnerships (74% response rate, n=344); relationship duration 
(73% response rate, n=337); type of relationship (75% response rate, n=344); condom use at last sex 
(69%, n=319) and CD4 cell count (81% response rate, =374). Measures to increase sample size on 
relationship duration and relationship type were taken combining these variables such that they 
included a category for those who reported themselves to not be in a relationship. 
3.8 Analysis 
Data were analyzed using Stata Version 10.0 (Stata Corporation, College Station, USA). All 
observations (n=459) in the data set were included in the analysis.  
3.8.1 Univariate and bivariate analyses 
Descriptive statistics were produced on socio-demographic data, sexual activity, health-related HIV 
outcomes and treatment status, as well as HRQL scores in the whole sample, regardless of whether 
they declared themselves to be sexually active or not. All continuous variables were non-parametric, 
hence medians were described. The Wilcoxon rank-sum test was applied to test for significant 
differences in the equality of the probability distributions of samples of those who were not on 
treatment and those who were. Similarly, the Kruskal-Wallis test was used to test the equality of the 
probability distributions between samples from different service settings. Pearson χ2 and Fisher‟s 
Exact tests were used to investigate the significance of any differences in the proportional 
distribution of the population over service settings and by treatment status. 
Bivariate analyses were performed on socio-demographic, behavioural, health and HRQL 
variables. Pearson χ2 and Fisher‟s Exact tests were used to test for the significance of an association 
of these predictors with sexual activity in the past month, condom use at last sexual intercourse 
among those who reported sexual activity in the past month, and number of partners, among those 
who were on ART and those who were not, as well as individuals attending different services. These 











3.8.2 Multivariate analyses 
Multivariate models were constructed using stepwise forward logistic regression analysis based on 
the log-likelihood ratio, to determine the predictors of sexual risk behaviour. First, a model was 
constructed to determine predictors of sexual activity in the past month. In a second model, factors 
associated with condom use at last sexual intercourse were examined among those who reported 
sexual activity in the past month. Those who claimed abstinence in the last month were not eligible 
for this analysis. A third model was developed to examine factors correlated with multiple partner 
acquisition over the past 6 months. 
In all three models, explanatory variables associated with the outcome variable (sexual activity 
in the past month, condom use at last sex and multiple partner change over the past 6 months) with 
a p-value ≤0.05 in the bivariate analyses were introduced in stepwise fashion in the logistic models 
initially, as were variables with a p-value ≤0.1, based on a priori knowledge. I put variables included 
age, sex, type of residence, income, employment status and educational level attained. Self-reported 
health status variables included time since HIV diagnosis. As data concerning CD4 cell counts were 
missing for 19% of the respondents, this variable was not introduced into any of the models. Sexual 
risk behaviour variables were included in each model if they were deemed neither to predict the 
outcome variable perfectly nor be highly correlated with the outcome variable. HRQL variables 
pertaining to mobility, pain, feelings and daily activities were entered separately into each model, and 
in each instance compared to a model that incorporated only the VAS composite scale with other 
input variables. Variables were retained based on likelihood ratio test and goodness of fit test scores. 
Variables pertaining to disclosure, treatment status and type of service attended were forced in the 
model, even if they were not significant at the 5% level in either bivariate analyses or the model 
itself. The final three models were chosen based on the best Goodness of Fit test score, given the 












4.1 Description of sample 
This survey collected data on 459 respondents. Of the women sampled, 20% (n=96) constituted 
PMTCT service attendees. Respondents from VCT services constituted 14% (n=64) of the sample, 
with 60% of these attendees being women. A greater proportion of men (62%, n=72) than women 
were sampled from HIV care services, which comprised 24% of the sample (n=111). Attendees 
from ART services made up 41% (n=188) of the sample, with 60% of these participants being 
female. 
Table 1 compares the socio-demographic characteristics, health status and sexual behaviour of 
participants stratified by services and ARV treatment status respectively. The median age of the 
sample was 32 years (IQR 27-38 years) and 95% of respondents were 45 years or younger. Women 
constituted 62% of the sample, and were more likely than men to be 35 years or younger (OR 71.7, 
p<0.001). While 81% of respondents had completed some years in secondary school, only 22% of 
respondents claimed to be employed or studying and 78% lived in a household with a monthly 
income of R2 000-00 or less. There were small yet significant differences between services, and 
treatment naïve and experienced respondents.  
Median time since HIV diagnosis was 12 months (IQR: 3-48 months) and for the 81% of the 
sample that reported a CD4 cell count, median CD4 cell count was 220.5 cells/µl (IQR: 95-370 
cells/µl). Less than half of respondents recalled CD4 cell counts of 200 cells/µl or less. There were 
high rates of disclosure in the sample, but disclosure differed significantly between services and by 
treatment status, the lowest disclosure rate being evident in women attending PMTCT. Overall, 59% 
of respondents were not on ART at the time of interview yet among those who were accessing 
treatment, 56% (n=106) had been receiving treatment for more than 12 months.  
In the sample, 32% (n=147) of respondents claimed that they had been abstinent in the past 
month. There was a significant difference in reported sexual activity between respondents accessing 
different services (p=0.002). Women attending PMTCT services reported the most sexual activity, 
with only 25% reporting to have been abstinent in the past month. Half of those attending HIV 
services reported abstinence, and one third of participants on ART claimed to have been abstinent 
in the past month. When stratifying by ARV treatment status, sexual activity was not significantly 
different between groups (p=0.685). Self-reported frequency of sexual activity post-HIV diagnosis 
was consistent with pre-diagnosis frequency. Data suggest that men were less than half as likely to 











Respondents reported a median frequency of 2 sexual acts over the past month, this frequency 
being significantly different across different services (p<0.001), with participants accessing PMTCT 
recalling a median of 3 sex events per month (IQR: 0.5-5) and VCT service attendees also recalling a 
median of 3 sex events per month (IQR: 0-4). Those in HIV care reported a median of only 1 sex 
act per month (IQR: 0-3). Frequency of sexual activity was not significantly different between 
groups, when stratifying by treatment status (p=0.270).  
Furthermore, 95% of the respondents who reported sexual activity in the past month declared 
that they were currently in a sexual relationship (p<0.001). Only 5% of PMTCT service attendees 
suggested that they were not in a sexual relationship, while 30% of respondents on ART recalled 
that they were not in a relationship. Approximately a quarter of VCT service attendees (23%) and 
HIV care patients (26%) recalled that they were not in a sexual relationship respectively. Half of the 
respondents who had been sexually active, were in a cohabiting relationship with their sexual 
partner, cohabitation being associated with a 21-fold increase in relative risk of sexual activity when 
compared to respondents who were not in a relationship (OR: 21.12, p<0.001). Half of all women 
attending PMTCT services stated that they were in a non-cohabiting relationship, while 
approximately only a third of participants in VCT services (33%); HIV Care (33%) and ART 
treatment services (35%) respectively, stated that they were in a non-cohabiting relationship.  
Consistent condom use over the last 6 months was significantly different between services 
(p<0.001), with only 31% of women attending PMTCT services recalling consistent use. 
Approximately half of VCT service (51%) and ART Care (52%) patients reported consistent 
condom use in the past 6 months, and 70% of HIV Care attendees reported consistent condom use. 
Whereas 70% of respondents on ART claimed to be using condoms consistently over the past 6 
months, only 40% of respondents not on ART reported consistent condom use in the past 6 
months (p<0.001). Of all respondents who reported sexual activity in the past month, 82% said that 
they had used a condom during their last sexual event. Condom use at last sex was lowest among 
PMTCT service attendees (72%) and highest among ARV-treated respondents (89%). Just over 
three quarters of VCT service attendees (76%) and HIV Care patients (78%) reported condom use 
at last sex. These differences were significant at service level (p=0.017). 
Most respondents reported that they had not used a dual method contraceptive before HIV 
diagnosis and significant differences in dual method use prior to diagnosis were found between 
services (p<0.001) and by treatment status (p<0.001). Few respondents went on to use dual 
methods post-HIV diagnosis, the proportions varying significantly between services (p<0.001). Only 
31% of respondents on ART reported dual method use after treatment initiation, but 70% reported 











PMTCT services (95%) suggested that they were not currently using dual methods. Current dual 
method use was highest in the ART service attendees, with 31% affirmed use. 
Among all respondents, 20% reported that they had not had a sexual partner in the last six 
months; while 67% reported having 1 partner and 13% reported having more than one partner in 
the last six months. There was a significant difference between the number of partners reported by 
men and women, and men were about 2.5 times as likely to have more than one partner than 
women (p<0.001). A significantly higher proportion of HIV Care attendees (21%) reported more 
than one sexual partner in the past 6 months than in other services, however, when stratified by 
treatment status, there was no significant difference between the frequency of partner acquisition 
among those who were treatment-naïve and those who were treatment experienced. PMTCT service 
attendees reported the highest proportion of single partnerships over the past 6 months: 95% 
suggested that they had had between 0 and 1 partner. 
HRQL scores suggested that a high proportion of respondents did not experience moderate 
or severe problems relating to mobility, pain, the ability to perform usual daily activities or anxiety 
and depression. Significant differences in self-rated mobility and pain were found between services, 
with those attending HIV Care reporting the highest proportion of health-related problems across 
all domains. A higher proportion of respondents on treatment reported fewer problems associated 











Table 1 Description of sample by service setting and ARV treatment status 
  Total PMTCT (%) VCT (%) 
 
HIV Care (%) 
 








N  459 96 64 111 188   271 188  
%  100 20.9 13.9 24.2 41.0   59% 41%  
            
Age category 
<25 years 62 34(35.4) 9(14.1) 9(8.1) 10(5.3) <0.001  52(19.2) 10(5.3) <0.001 
25-35 years 238 56(58.3) 56(50.5) 56(50.5) 97(51.6)   141(52) 97(51.6)  
>35 years 159 6(6.25) 46(41.4) 46(41.4) 81(43.1)   78(28.8) 81(43.1)  
            
Sex Female 285 96 (100) 38 (59.4) 39 (35.1) 112 (59.6) <0.001  173(63.8) 112(59.6) 0.355 Male 174 0 (0) 26 (40.6) 72 (66.1) 76(40.4)   98(36.2) 76(40.4)  
            
Residence type Informal 227 51 (53.1) 30 (46.9) 52 (46.9) 94 (50) 0.798  133(49.1) 94(50) 0.846 Formal 232 45 (46.9) 34 (53.1) 59 (53.2) 94 (50)   138(50.9) 94(50)  
            
Income 
R0-R999-00 203 24(27.0) 24(38.7) 64(60.4) 91(49.7) <0.001  112(43.6) 91(49.7) 0.434 
R1 000-R 2 999 220 58(65.2) 37(59.7) 40(37.7) 85(46.5)   135(52.5) 85(46.5)  
R3 000-R7 999 17 7(7.9) 1(1.6) 2(1.9) 7(3.8)   10(3.9) 7(3.8)  
            
Employment Unemployed 355 69 (71.9) 44 (68.8) 90 (81.1) 152 (81.3) 0.075  203(74.9) 152(81.3) 0.108 Working or studying 103 27 (28.1) 20 (31.3) 21(18.9) 35 (18.7)   68(25.1) 35(18.7)  
            
Education None/primary 82 6(6.3) 13(2.3) 24(21.6) 39(20.7) 0.011  43(15.9) 39(20.7) 0.180 Secondary/tertiary 377 90(93.8) 51(79.7) 87(78.4) 149(79.3)   228(84.1) 149(79.3)  
            
In a current relationship No 103 5(5.2) 15(23.8) 29(26.8) 54(29.8) <0.001  49(18.4) 54(29.8) 0.005 Yes 345 91(94.8) 48(76.2) 79(73.2) 127(70.2)   218(81.7) 127(70.2)  
            
Type of relationship 
Not in a relationship 103 5(5.2) 15(23.8) 29(26.9) 54(29.8) <0.001  49(18.4) 54(29.8) 0.018 
Cohabiting 174 41(42.7) 27(42.9) 43(39.8) 63(34.8)   111(41.6) 63(34.8)  
Non-cohabiting 171 50(52.1) 21(33.3) 36(33.3) 64(35.4)   107(40.1) 64(35.4)  
            
Relationship duration 
Not in a relationship 103 5 (5.21) 15 (23.8) 29 (26.9) 54 (29.8) <0.001  49 (18.4) 54 (29.8) 0.001 
In a relationship ≤ 3 months 154 49 (51.0) 24 (38.1) 36 (33.3) 45 (24.9)   109 (40.8) 45 (24.9)  
In a relationship > 3months 191 42 (43.8) 24 (38.1) 43 (39.8) 82 (45.3)   109 (40.8) 82 (45.3)  
            
Child shared (current 
partner) 
No 115 27(50) 19(48.7) 22(34.4) 47(42.7) 0.315  68(43.3) 47(42.7) 0.924 
Yes 152 27(50) 22(34.4) 47(42.7) 115(43.1)   89(56.7) 63(57.3)  
            
Sexually active in past 
month 
No 147 24(25) 16(27.1) 52(49.1) 55(33.3) 0.002  92(35.3) 55(33.3) 0.685 












Table 1 Description of sample by service setting and ARV treatment status (cont) 
  Total PMTCT (%) VCT (%) 
 
HIV Care (%) 
 








           
Median sex acts in the past month 2 3 3 1 2 <0.001  2 2 0.270 
 IQR (0-4) (0.5-5) (0-4) (0-3) (0-3)   (0-4) (0-3)  
            
Condom use at last sex No 61 21(28) 11(23.4) 15(21.7) 14(10.9) 0.017  47(24.6) 14(10.9) 0.002 
Yes 258 54(72) 36(76.6) 54(78.3) 114(89.1)   144(75.4) 114(89.1)  
            
Condom use in past 6 
months 
Consistent use 199 28(31.5) 50(51.6) 99(70.7) 199(52.1) <0.001  100(41.3) 99(70.7) <0.001 
Inconsistent use 183 61(68.5) 47(48.5) 41(29.3) 183(47.9)   142(58.7) 41(29.3)  
            
Sexual partners in last 6 
months 
0-1 partner 397 91(95.8) 58 (90.6) 87 (78.4) 161 (87.0) 0.002  236 (87.4) 161 (87.0) 0.905 
2 or more partners 58 4 (4.2) 6 (9.4) 24 (21.6) 24 (13.0)   34 (12.6) 24 (12.6)  
            
Median time since HIV diagnosis (months) 12 3 7 12 36 <0.001  4 36 <0.001 
 IQR (3-48) (1-7.5) (1-36) (3-24) (12-60)   (1-24) (12-60)  
            
Knowledge of serostatus ≤12 months 245 75(78.1) 41(64.1) 74(66.7) 55(29.3) <0.001  190(70.1) 55(29.3) <0.001 
>12 months 214 21(21.9) 23(35.9) 37(33.3) 133(70.7)   81(29.9) 133(70.7)  
            
CD4 cell count ≤ 200 cells/µl 168 16(16.7) 19(47.5) 56(72.7) 77(47.8) <0.001  91(42.7) 77(47.8) 0.455 
≤350 cells/µl 106 34(35.4) 11(27.5) 15(19.5) 46(28.6)   60(28.2) 46(28.6)  
>350 cells/µl 100 46(47.9) 10(25) 6(7.8) 38(23.6)   62(29.1) 38(23.6)  
            
Disclosure status Did not disclose to someone 37 26(27.1) 4(6.3) 4(3.6) 3(1.6) <0.001  34(12.6) 3(1.6) <0.001 
Disclosed to someone 422 70(72.9) 60(93.8) 107(96.4) 185(98.4)   237(87.5) 185(98.4)  
            
Frequency of sex post-
HIV diagnosis 
More frequently 11 0(0) 7(10.9) 3(2.7) 1(0.5) <0.001  10(3.7) 1(0.5) 0.012 
Less frequent/no sex 77 23(24) 12(18.8) 18(16.2) 24(12.9)   53(19.6) 24(12.9)  
About the same frequency 369 73(76) 45(70.3) 90(81.1) 161(86.6)   208(76.8) 161(86.6)  
            
New sexual partners post-
HIV diagnosis 
0-1 partner 394 90 (93.8) 59 (92.2) 92 (82.9) 153 (81.4) 0.012  241 (88.9) 153 (81.4) 0.023 
2 or more partners 65 6 (6.3) 5 (7.8) 19 (17.1) 35 (18.6)   30 (11.1) 35 (18.6)  
            
Dual method use pre- HIV 
diagnosis 
No 412 75(78.1) 57(89.1) 103(92.8) 177(94.2) <0.001  235(86.7) 177(94.2) 0.010 
Yes 47 21(21.9) 7(10.9) 8(7.2) 11(5.9)   36(13.3) 11(5.9)  
            
Dual method use post- 
HIV diagnosis 
No 354 87(90.6) 45(70.3) 90(81.1) 132(70.2) <0.001  222(0) 132(0) 0.003 
Yes 105 9(9.4) 19(29.7) 21(18.9) 56(29.8)   49(18.1) 56(29.8)  
            
Current dual method use No 353 92(95.8) 47(73.4) 86(77.5) 128(68.1) <0.001  225(83) 128(68.1) <0.001 











Table 1 Description of sample by service setting and ARV treatment status (cont) 
  Total PMTCT (%) VCT (%) 
 
HIV Care (%) 
 








HRQL – Mobility No problems 237 55(57.3) 32(50) 41(36.9) 109(58.3) 0.011  128(47.2) 109(58.3) 0.046 
Some problems 205 37(38.5) 29(45.3) 65(58.6) 74(39.6)   131(48.3) 74(39.6)  
Severe problems 16 4(4.2) 3(4.7) 5(4.5) 4(2.1)   12(4.4) 4(2.1)  
            
HRQL - Usual activities No problems 373 78(81.3) 54(84.4) 81(73) 160(85.6) 0.139  213(78.6) 160(85.6) 0.097 
Some problems 81 18(18.8) 9(14.1) 29(26.1) 25(13.4)   56(20.7) 25(13.4)  
Severe problems 4 0(0) 1(1.6) 1(0.9) 2(1.1)   2(0.7) 2(1.1)  
            
HRQL - Pain/Discomfort No problems 267 62(64.6) 34(53.1) 50(45.1) 121(64.7) 0.025  146(53.9) 121(64.7) 0.067 
Some problems 164 29(30.2) 25(39.1) 54(48.7) 56(30)   108(39.9) 56(30)  
Severe problems 27 5(5.2) 5(7.8) 7(6.3) 10(5.4)   17(6.3) 10(5.4)  
            
HRQL - 
Anxiety/Depression 
No problems 366 77(80.2) 49(77.8) 89(80.2) 151(80.8) 0.996  215(79.6) 151(80.8) 0.947 
Some problems 74 16(16.7) 11(17.5) 18(16.2) 29(15.5)   45(16.7) 29(15.5)  
Severe problems 17 3(3.1) 3(4.8) 4(3.6) 7(3.7)   10(3.7) 7(3.7)  
            
HRQL - Composite VAS 
scale - tertiles 
1 329 64(66.7) 43(68.3) 84(75.7) 138(73.8) 0.545  191(70.7) 138(73.8) 0.424 
2 123 31(32.3) 19(30.2) 27(24.3) 46(24.6)   77(28.5) 46(24.6)  
3 5 1(1) 1(1.6) 0(0) 3(1.6)   2(0.7) 3(1.6)  
            
On ART No 271 96(100) 64(100) 111(100) 0(0) <0.001     











4.2 Determinants of sexual activity 
Bivariate associations between sexual activity in the past month and potential predictors are presented 
in Table 2. Table 3 outlines the determinants of sexual activity, adjusted through multivariate logistic 
regression. 
A total of 279 (61%) out of the 459 respondents declared themselves to be sexually active in the 
past month. In the bivariate analyses, the odds of sexual activity were lower in respondents aged 25 
years and older (p=0.003). Respondents aged 25-35 years had an 18% reduced relative risk of having 
had sexual intercourse in the last month, while respondents over the age of 35 years had a 58% reduced 
risk of having had sexual intercourse in the last month. When adjusting for other factors in the 
multivariate analyses, age was not a significant predictor of sexual activity in this sample (Table 3). 
Crude associations suggested that men were significantly less likely to have been sexually active in 
the past month than women (OR 0.42, p<0.001). Similarly, a strong association between respondent 
sex and sexual activity was observed with multivariate adjustment, with men being half as likely to have 
been sexually active in the past month as women (OR: 0.50, p=0.02). 
In the bivariate analyses, respondents who had a monthly household income of R1 000-00 or 
more were more likely to have been sexually active in the past month than those earning less than R1 
000-00. While similar trends were seen in the multivariate model, these results were not significant 
(p>0.1). Being either employed or a student was c rrelated with a significantly higher probability of 
sexual activity in the bivariate analysis (OR: 2.02, p=0.007). After statistical adjustment those who were 
employed or studying were less than twice as likely to be sexually active (OR: 1.77, p=0.06). The 
unadjusted association between educational level and sexual activity suggested an insignificant decrease 
in sexual risk with level attained (OR: 0.94, p=0.809). This decrease was more pronounced in the 
logistic regression, where respondents with a secondary or tertiary level education were almost half as 
likely to be sexually active (OR: 0.53, p=0.04).  
Crude analyses suggested that condom use was significantly higher among sexually active 
respondents, who had a 2 fold increase in the relative risk of using a condom at last sex (OR: 2.17, 
p=0.04), and were 64% less likely to have used a condom inconsistently in the past 6 months (OR: 
0.36, p<0.001). Furthermore, the unadjusted analyses shows that respondents who were sexually active 
were half as likely to report the use of a dual method pre-HIV diagnosis (OR 0.57, p=0.081), yet more 
than twice as likely to report dual method use at the time of interview (OR: 2.45, p=0.001).  
The crude association between sexual activity and the type of service attended by respondents 
was highly significant (p=0.002), however, when entered into the multivariate model, the significance of 











on treatment versus those who were not on treatment in the bivariate analyses. This factor was 
dropped from the regression model due to high collinearity with the respondent‟s service attended, 
which also provided a better model fit in the likelihood ratio test. 
The time since a respondent‟s HIV diagnosis, as well as disclosure status was not significantly 
associated with being sexually active in the past month in bivariate analyses. Based on a priori 
knowledge, these factors were forced in the multivariate model regardless, but no significant 
associations between these factors and sexual activity in the past month were rendered. 
Unadjusted analyses of HRQL factors suggested that respondents who reported sexual activity in 
the past month were significantly less likely to report problems associated with mobility (p=0.032) or 
pain and discomfort (p=0.043) than those who stipulated that they had not been sexually active in the 
past month. The stepwise inclusion of HRQL factors in the regression analysis provided a poorer fit 
than the composite measure of the VAS scale in the likelihood ratio tests. The latter was forced in the 












Table 2 Bivariate analysis: sexual activity 
  Sexual activity in past month   
  Total No Yes pvalue OR (95% CI) 
  n=459 n=147(%) n= 278 (%)  unadjusted 
       
Age <25 years 62(13.5) 15(10.2) 43(15.4) 0.003  
25-35 years 238(51.8) 68(46.3) 159(57)  0.82 (0.42-1.57) 
>35 years 159(34.6) 64(43.5) 77(27.6)  0.42 (0.21-0.82) 
       
Sex Female 285(62.1) 68(46.3) 188(67.4) 0.000  
Male 174(37.9) 79(53.7) 91(32.6)  0.42 (0.28-0.63) 
       
Residence type Informal 227(49.5) 69(46.9) 146(52.3) 0.290  
Formal 232(50.5) 78(53.1) 52.33(0)  0.81 (0.54-1.20) 
       
Income <R1 000 80(55.6) 80(55.6) 103(38.6) 0.004  
R1 000 - R2 999 211(51.3) 60(41.7) 151(56.6)  1.95 (1.29-2.97) 
R3 000 - R 7 999 17(4.1) 4(2.8) 13(4.9)  2.52 (0.79-8.04) 
       
Employment status unemployed 327(76.8) 124(84.4) 203(72.8) 0.007  
employed/studying 99(23.2) 23(15.7) 76(27.2)  2.02 (1.20-3.39) 
       
Education level 0-primary level 78 (18.3) 26(33.3) 121(34.8) 0.809  
secondary or more 348(81.7) 52(66.7) 227(65.2)  0.94 (0.56-.58) 
       
In a current 
relationship 
No 74 62(44.3) 12(4.3) <0.001  
Yes 344 78(55.7) 266(95.7)  17.62 (9.04-34.35) 
       
Type of relationship Not in a relationship 74(17.7) 62(44.2) 12(4.3) <0.001  
Cohabiting 




relationship 171(40.9) 44(31.4) 127(45.7)  14.91 (7.35-30.24) 
       
Relationship 
duration 
Not in a relationship 74(17.7) 62(44.3) 12(4.3) <0.001  
In a relationship <= 3 
months 154(36.8) 32(22.9) 122(43.9)  19.70 (9.49-40.89) 
In a relationship > 3 
months 190(45.5) 46(3.9) 144(51.8)  16.17 (8.02-32.62) 
       
Shares a child with 
current partner 
No 115 12(18.5) 103(51.2) <0.001  
Yes 151 53(81.5) 98(48.8)  0.91 (0.73-1.14) 
       
Number of sexual 
partners in the last 
6 months 
0-1 partner 365 132(89.8) 233(84.4) 0.126  
>1 partner 58 15(10.2) 43(15.6)  1.62 (0.87-3.04) 
       
Condom use at last 
sex 
No 59 12(30.8) 47(17) 0.040  
Yes 256 27(69.2) 229(83)  2.17 (1.02-4.58) 
       
Frequency of 
condom use in last 
6 months 
Consistent use 198 35(34) 163(58.8) <0.001  
Inconsistent use 182 68(66) 114(41.2)  0.36 (0.22-0.58) 
       
Service attended PMTCT 96 24(16.3) 72(25.8) 0.002  
VCT 59 16(10.9) 43(15.4)  0.90 (0.43-1.87) 
HIV Care 106 52(35.4) 54(19.4)  0.35 (0.19-0.63) 
ART Care 165 55(37.4) 110(39.4)  0.67 (0.38-1.17) 
       
Sexual activity 
post-HIV diagnosis 
More frequently 11 3(2.1) 8(2.9) 0.077  
Less frequently 76 18(12.3) 58(20.8)    
About the same 
frequency 338 125(85.6) 213(76.3)  0.64 (0.17-2.45) 
       
Number of new 
sexual partners 
post-HV diagnosis 
0-1 partner 363 124(84.4) 239(85.7) 0.717  












Table 2 Bivariate analysis: sexual activity (cont) 
  Sexual activity in past month   
  Total No Yes pvalue OR (95% CI) 
  n=459 n=147(%) n= 278 (%)  unadjusted 
       
Dual method use 
before HIV 
diagnosis 
No 383 127(86.4) 256(91.8) 0.081  
Yes 43 20(13.6) 23(8.2)  0.57 (0.30-1.08) 
       
Dual method use 
after HIV diagnosis 
No 324 119(81) 205(73.5) 0.086  
Yes 102 28(19.1) 74(26.5)  1.53(0.94-2.50) 
       
Dual method use 
post-ART initiation 
No 360 134(91.2) 226(81) 0.006  
Yes 66 13(8.8) 53(19)  2.42 (1.27-4.60) 
       
Current dual 
method use 
No 324 126(85.7) 198(71) 0.001  
Yes 102 21(14.3) 81(29)  2.45 (1.45-4.17) 
       
Time since HIV 
diagnosis 
0-12 months 235(55.2) 87(59.2) 148(53.1) 0.226  
>12months 191(44.8) 60(40.8) 131(47.0)  1.28 (0.86-1.92) 
       
CD4 count recall <=200 cells/µL 155(36.4) 59(40.1) 96(34.4) 0.467  
<=350 cells/µL 97(22.8) 30(20.4) 67(24.0)  1.37 (0.80-2.35) 
>350 cells/µL 174(40.9) 58(39.5) 116(41.6)  2.17 (1.21-3.88) 
       
Disclosure status Did not disclose to 
someone 36 9(6.1) 27(9.7) 0.210  
Disclosed to someone 390 138(93.9) 252(90.3)  0.61 (0.28-1.33) 
       
On ART No 261 92(62.6) 169(60.6) 0.685  
Yes 165 55(37.4) 110(39.4)  1.09 (0.72-1.64) 
       
Duration on ART Not on ART 261(61.2) 92(62.6) 169(60.6) 0.566  
On ART (0-11 
months) 75(17.6) 28(19.1) 47(16.9)  0.91 (0.54-1.56) 
On ART (12 or more 
months) 90(21.1) 27(18.3) 63(16.9)  1.27 (0.76-2.13) 
       
Sexual activity 
post-ART initiation 
More frequently 14 2(4.2) 12(10.5) 0.014  
Less frequently 36 5(10.4) 31(27.2)  1.03 (0.18-6.07) 
About the same 
frequency 112 41(85.4) 71(62.3)  0.29 (0.06-1.35) 
       
Number of sexual 
partners post-ART 
initiation 
0-1 partner 138 48(96) 90(90.9) 0.262  
>1 partner 11 2(4) 9(9.1)  2.4(0.49-11.55) 
       
Quality of life - 
mobility 
No problems 222(52.1) 67(45.6) 155(55.6) 0.032  
Some problems 191(44.8) 72(49.0 119(42.7)  0.71 (0.47-1.08) 
Confined to bed 13(3.1) 8(5.4) 5(1.8)  0.27 (0.09-0.86) 
       
Quality of life - pain 
or discomfort 
No pain/discomfort 249(58.4) 78(53.1) 171(61.3) 0.043  
Moderate 
pain/discomfort 154(36.2) 56(38.1) 98(35.1)  0.80 (0.52-1.22) 
Extreme 
pain/discomfort 3(5.4) 13(8.8) 10(3.6)  0.35 (0.15-0.83) 
       
Quality of life - 
feelings 
No anxiety/depression 341(80.2) 116(79.5) 225(80.7) 0.392  
Moderate 
anxiety/depression 68(16.0) 22(15.1) 46(16.5)  1.08 (0.62-1.88) 
Extreme 
anxiety/depression 16(3.7) 8(5.5) 8(2.9)  0.52 (0.19-1.41) 
       
Quality of life - 
execution of daily 
activities 
No problem 349(81.9) 113(76.9) 236(84.6) 0.102  
Some problems 74(174) 32(21.8) 42(15.1)  0.63 (0.38-1.05) 
Severe problems 3(0.7) 2(1.36) 1(0.4)  0.24 (0.02-2.67) 
       
Quality of life scale 
(tertile) 
1 166 59(40.1) 107(38.4) 0.152  
2 125 35(23.8) 90(32.3)  1.42 (0.86-2.35) 
3 426 53(36.1) 82(29.4)  0.85 (0.53-1.36) 











Table 3 Multivariate analysis: sexual activity in the last month 
Variable Odds Ratio p- value 95% CI 
Age 25-35 years (Ref: Age <25years) 0.92 0.84 (0.43-1.97) 
Age >35 years 0.49 0.11 (0.21-1.16) 
Male (Ref: Female) 0.50 0.02 (0.28-0.90) 
Income R1000 - R2999 (Ref: Income <R1 000) 1.38 0.19 (0.86-2.22) 
Income >R3000 1.51 0.54 (0.41-5.57) 
Employed or Studying (Ref: Unemployed) 1.77 0.06 (0.98-3.18) 
Secondary or tertiary education (Ref: no education/primary) 0.53 0.04 (0.29-0.96) 
Time since HIV diagnosis >12 months  (Ref: ≤12 months) 1.36 0.21 (0.84-2.21) 
Disclosed status to someone (Ref: Not disclosed) 0.76 0.55 (0.31-1.86) 
Attending VCT (Ref: Attending PMTCT) 1.74 0.21 (0.73-4.17) 
Attending HIV Care 0.71 0.38 (0.33-1.52) 
Attending ART Care 1.17 0.68 (0.56-2.44) 
VAS composite scale 2 (Ref: VAS composite scale 1) 1.55 0.12 (0.89-2.71) 
VAS composite scale 3 0.67 0.16 (0.38-1.16) 
 
4.3 Factors associated with barrier method use – condom use at last sex 
Bivariate associations between condom use at last sexual intercourse are outlined in Table 4. None of 
the socio-demographic factors assessed were significantly associated with condom use at last sex event, 
apart from respondent‟s monthly income, which was significant at the 6% level. The multivariate model 
(Table 5) shows that income remained the strongest single predictor after statistical adjustment. 
Respondents who were earning more than R3 000 per month were 77% less likely to have used a 
condom at last sex than respondents earning less than R1 000 er month (p=0.06).  
In the bivariate analyses, respondent‟s time since HIV diagnosis was significantly associated with 
condom use at last sex at the 10% level (p=0.099). Furthermore, respondents who had disclosed their 
HIV status to someone had more than a 2 fold increased relative risk of using a condom at last sex than 
those who had not disclosed their serostatus (p=0.018). There was a significant crude association 
between the respondent‟s service attended and condom use at last sex. (p=0.007), and those who were 
on ART had a three-fold increased relative risk of using a condom at last sex than those who were not 
on ART (p=0.002). In multivariate analysis, time since HIV diagnosis, disclosure status and service 
attended were forced in the model, however, none of these factors were significant predictors of 
condom use at last sex. Respondents on ART continued to have a three-fold increased relative risk of 
using a condom at last sex in the multivariate analysis (p=0.04). 













Table 4 Bivariate analysis: condom use at last sex 
  Condom use at last sex   
  Total No Yes p-value OR (95% CI) 
  (n=276) n=47(%) n=229(%)  unadjusted 
       
Age <25 years 43 9(19.2) 34(14.9) 0.219  
25-35 years 158 30(63.8) 128(55.9)  1.13 (0.49-2.60) 
>35 years 75 8(17) 67(29.3)  2.22 (0.79-6.26) 
       
Sex Female 186 34(72.3) 152(66.4) 0.427  
Male 90 13(27.7) 77(33.6)  1.32 (0.66-2.66) 
       
Residence type Informal 144 21(44.7) 123(53.7) 0.259  
Formal 132 26(55.3) 106(46.3)  0.70 (0.37-1.31) 
       
Income <R1 000 102 13(29.6) 89(40.5) 0.069  
R1 000 - R2 999 149 26(59.1) 123(55.9)  0.69(0.34-1.42) 
R3 000 - R 7 999 13 5(11.4) 8(3.6)  0.23 (0.07-0.82) 
       
Employment status unemployed 202 34(72.3) 168(73.4) 0.885  
employed/studying 74 13(27.7) 61(26.6)  0.95 (0.47-1.92) 
       
Education level None/primary 49 6(12.8) 43(18.8) 0.326  
Secondary/tertiary 227 41(87.2) 186(81.2)  0.63 (0.25-1.59) 
       
In a current relationship No 12 3(6.4) 9(4) 0.433  
Yes 263 44(93.6) 219(96.1)  1.66 (0.43-6.38) 
       
Type of relationship Not in a relationship 12 3(6.4) 9(4) 0.578  
Cohabiting relationship 136 25(53.2) 111(48.7)  1.48 (0.37-5.86) 
Non-cohabiting 
relationship 127 19(40.4) 108(47.4)  1.89 (0.47-7.64) 
       
Relationship duration Not in a relationship 12 3(6.4) 9(4) 0.458  
In a relationship ≤3 
months 122 23(48.9) 99(43.4)  1.43 (0.36-5.72) 
In a relationship > 3 
months 141 21(44.7) 120(52.6)  1.90 (0.48-7.62) 
       
Child shared (current 
partner) 
No 103 20(71.4) 83(48.8) 0.040  
Yes 95 8(28.6) 87(51.2)  2.62. (1.09-6.28) 
       
Number of sexual partners 
in the last 6 months 
0-1 partner 231 44(93.6) 187(82.7) 0.074  
>1 partner 42 3(6.4) 39(17.3)  3.06 (0.90-10.35) 
       
Service attended PMTCT 72 19(40.4) 53(23.1) 0.007  
VCT 41 10(21.3) 31(13.5)  0.23 (0.46-2.69) 
HIV Care 54 9(19.2) 45(19.7)  1.29 (0.74-4.35) 
ART Care 109 9(19.2) 100(43.7)  3.15 (1.69-9.41) 
       
Time since HIV diagnosis 0-12 months 146 30(63.8) 116(50.7) 0.099  
>12months 130 17(36.2) 113(49.3)  1.72 (0.90-3.29) 
       
CD4 count recall <=200 cells/µL 93 17(43.6) 76(39) 0.847  
<=350 cells/µL 67 10(25.6) 57(29.2)  1.28 (0.54-2.99) 
>350 cells/µL 74 12(30.8) 62(31.8)  1.16 (0.51-2.60) 
       
Disclosure status Did not disclose to 
someone 27 9(19.2) 18(7.9) 0.018  
Disclosed to someone 249 38(80.9) 211(92.1)  2.78 (1.16-6.64) 
       
Frequency of condom use 
in last 6 months 
Consistent use 163 3(6.5) 160(69.9) <0.001  
Inconsistent use 112 43(93.5) 69(30.1)  0.03 (0.01-0.10) 
       
Frequency of sex post-HIV 
diagnosis 
More frequently 8 3(6.4) 5(2.2) 0.140  
Less frequently 58 12(25.5) 46(20.1)  2.30 (0.48-11.01) 
About the same 












Table 4 Bivariate analysis: condom use at last sex (cont) 
  Condom use at last sex   
  Total No Yes p-value OR (95% CI) 
  (n=276) n=47(%) n=229(%)  unadjusted 
       
       
Number of new sexual 
partners post-HV diagnosis 
0-1 partner 236 41(87.2) 195(85.2) 0.712  
>1 partner 40 6(12.8) 34(14.9)  1.19 (0.47-3.02) 
       
Dual method use before 
HIV diagnosis 
No 253 44(93.6) 209(91.3) 0.776  
Yes 23 3(6.4) 20(8.7)  1.40 (0.40-4.93) 
       
Dual method use after HIV 
diagnosis 
No 204 41(87.2) 163(71.2) 0.028  
Yes 72 6(12.8) 66(28.8)  2.77 (1.12-6.83) 
       
Dual method use post-ART 
initiation 
No 57 9(100) 48(48) 0.003  
Yes 52 0(0) 52(52)   
       
Current dual method use No 197 43(91.5) 154(67.3) 0.002  
Yes 79 4(8.5) 75(32.8)  5.24 (1.81-15.13) 
       
On ART No 167 38(80.9) 129(56.3) 0.002  
Yes 109 9(19.2) 100(43.7)  3.27 (1.51-7.08) 
       
Duration on ART Not on ART 167 38(80.9) 129(56.3) 0.005  
On ART (0-11 months) 47 5(10.6) 42(18.3)  2.47 (0.91-6.69) 
On ART (12 or more 
months) 62 4(8.5) 58(25.3)  4.27 (1.46-12.53) 
       
Sexual activity post-ART 
initiation 
More frequently 12 0(0) 12(11.8) 0.445  
Less frequently 31 2(18.2) 29(28.4)  0.00 
About the same 
frequency 70 9(81.8) 61(59.8)  0.00 
       
Sexual partners post-ART 
initiation 
0-1 partner 89 8(100) 81(90) 0.348  
>1 partner 9 0(0) 9(10)  0.00 
       
HRQL - Mobility No problems 154 27(57.5) 127(55.5) 0.293  
Some problems 117 18(38.3) 99(43.2)  1.17(0.61-2.24) 
Confined to bed 5 2(4.3) 3(1.3)  0.2 (0.05-2.00) 
       
HRQL - Pain/Discomfort No pain/discomfort 170 30(63.8) 140(61.1) 0.761  
Moderate 
pain/discomfort 96 15(31.9) 81(35.4)  1.16 (0.59-2.28) 
Extreme 
pain/discomfort 10 2(4.3) 8(3.5)  0.86 (0.17-4.24) 
       
HRQL - 
Anxiety/Depression 
No anxiety/depression 223 37(78.7) 186(81.2) 0.725  
Moderate 
anxiety/depression 45 8(17) 37(16.2)  0.92 (0.40-2.13) 
Extreme 
anxiety/depression 8 2(4.3) 6(2.6)  0.60 (0.12-3.07) 
       
HRQL - usual activities No problem 233 39(83) 194(84.7) 0.720  
Some problems 42 8(17) 34(14.9)  0.85 (0.37-1.99) 
Severe problems 1 0(0) 1(0.4)  0 
       
Quality of life scale (tertile) 1 106 17(36.2) 89(38.9) 0.684  
2 90 18(38.3) 72(31.4)  0.76 (0.37-1.59) 
3 80 12(25.5) 68(29.7)  1.08 (0.48-2.42) 












Table 5 Multivariate analysis: condom use at last sex 
Variable Odds Ratio p- value 95% CI 
Age 25-25 years (Ref: Age <25 years) 0.63 0.38 (0.23-1.76) 
Age >35 years 1.08 0.91 (0.29-3.97) 
Male (Ref: Female) 0.72 0.50 (0.28-1.87) 
Income R1000- R2999 (Ref: <R1 000) 0.82 0.63 (0.38-1.80) 
Income >R3000 0.26 0.06 (0.06-1.04) 
>1 sex partner in past 6 months (Ref: 0-1 sex partner in past 6 months) 2.89 0.12 (0.77-10.81) 
Time since HIV diagnosis >12 months (Ref: ≤12 months) 0.92 0.84 (0.42-2.03) 
Disclosed status to someone (Ref: Not disclosed) 1.48 0.49 (0.48-4.49) 
Attending VCT (Ref: Attending PMTCT) 0.88 0.82 (0.30-2.56) 
Attending HIV Care 1.18 0.77 (0.38-3.70) 
Attending ART Care 3.20 0.04 (1.03-9.95) 
VAS composite scale 2 (Ref: VAS composite scale 1) 0.98 0.96 (0.43-2.22) 
VAS composite scale 3 1.44 0.44 (0.57-3.59) 
 
4.4 Multiple partners over the past 6 months 
In Table 6 which depicts the crude analyses, the relative risk of having more than one partner in the 
past six months increased almost five-fold for men, when compared with wome  (OR: 4.90, p<0.001). 
The strength of this association held in the adjusted analyses (Table 7), where men were 3.48 times as 
likely as women to have had more than one partner in the last six months (p<0.001), making the 
respondent‟s sex the singularly the most significant predictor of multiple sexual partnerships in the past 
six months. In the bivariate analyses, secondary level education or higher was associated with a 52% 
decreased relative risk in acquiring two or more sexual partners in the past six months, however, this 
association was highly insignificant in the final logistic model (OR:0.72, p=0.35).  
Bivariate analyses showed that there were significant differences in the probability of multiple 
partner acquisition in the past six months and service attended (p=0.002). Yet respondents on ART 
were no more likely to have more than more than one sexual partner in the past six months than those 
not on ART (OR: 1.03, p=0.905). Neither of these factors was significant in multivariate analysis, 
despite the service setting being forced in the model. Similarly, time since HIV diagnosis and disclosure 
status did not feature as significant predictors of multiple sexual partnerships in either the bivariate or 
multivariate analyses.  
HRQL factors were not associated with increased probability of multiple sexual partnerships in 
bivariate analyses, however the composite measure of HRQL was significantly associated with multiple 
partner acquisition over six months. Respondents who claimed to fall in the third tertile of self-
perceived health status were 55% more likely than those who fell into the lowest tertile of self-
perceived health risk to have more than one new sexual partnership in the past six months (p=0.033). 
This association was maintained in adjusted analyses, where respondents in the second tertile were 49% 
more likely to acquire more than one sexual partner over the past six months than those who were in 












Table 6 Bivariate analysis: number of sexual partners in last 6 months 
  Sexual partners in the last 6 months   
  Total 0-1 >1 p- value OR (95% CI) 
      unadjusted 
       
Age <25 years 62 58(14.6) 4(6.9) 0.073  
25-35 years 235 208(52.4) 27(46.6)  1.57(0.62-3.98) 
>35 years 158 131(33) 27(46.6)  2.53 (1.00-6.40) 
       
Sex Female 283 266(67) 17(29.3) <0.001  
Male 172 131(33) 41(70.7)  4.90 (2.68-8.95) 
       
Residence type Informal 224 190(47.9) 34(58.6) 0.126  
Formal 231 207(52.1) 24(41.4)  0.65 (0.37-1.13) 
       
Income <R1 000 201 169(44.4) 32(57.1) 0.196  
R1 000 - R2 999 219 197(51.7) 22(39.3)  0.59 (0.33-1.05) 
R3 000 - R 7 999 17 15(3.9) 2(3.6)  0.70 (0.15-3.23) 
       
Employment status unemployed 351 303(76.5) 48(82.8) 0.289  
employed/studying 103 93(23.5) 10(17.2)  0.68 (0.33-1.39) 
       
Education level 0-primary level 81 64(16.1) 17(29.3) 0.014  
secondary or more 374 333(83.9) 41(70.7)  0.48 (0.25-0.89) 
       
In a current 
relationship 
No 103 89(22.9) 14(24.6) 0.786  
Yes 342 299(77.1) 43(75.4)  0.91 (0.48-1.75) 
       
Type of relationship Not in a relationship 103 89(22.9) 14(24.6) 0.957  
Cohabiting 
relationship 172 150(38.7) 22(38.6)  0.93 (0.45-1.91) 
Non-cohabiting 
relationship 445 149(38.4) 21(36.8)  0.90 (0.43-1.85) 
       
Relationship 
duration 
Not in a relationship 103 89(22.9) 14(24.6) 0.935  
In a relationship <= 3 
months 153 133(34.3) 20(35.1)  0.96 (0.46-1.99) 
In a relationship > 3 
months 189 166(42.8) 23(40.4)  0.88 (0.43-1.80) 
       
Shares a child with 
current partner 
No 0 (0) (0) 0.690  
Yes 151 130(57.3) 21(53.9)  0.87 (0.44-1.72) 
       
Frequency of 
condom use in last 6 
months 
Consistent use 196 165(50.8) 31(57.4) 0.366  
Inconsistent use 183 160(49.2) 23(42.6)  0.77 (0.43-1.37) 
       
Sexual activity post-
HIV diagnosis 
More frequently 11 9(2.3) 2(3.5) 0.097  
Less frequently 77 62(15.7) 15(25.9)  1.09 (0.21-5.57) 
About the same 
frequency 366 325(82.1) 41(70.7)  0.57 (0.12-2.72) 
       
Number of new 
sexual partners 
post-HV diagnosis 
0-1 partner 391 360(90.7) 31(53.5) <0.001  
>1 partner 64 37(9.3) 27(46.6)  8.47 (4.57-15.71) 
       
Dual method use 
before HIV 
diagnosis 
No 408 352(88.7) 56(96.6) 0.065  
Yes 47 45(11.3) 2(3.5)  0.28 (0.07-1.18) 
       
Dual method use 
after HIV diagnosis 
No 350 303(76.3) 47(81) 0.426  
Yes 105 94(23.7) 11(19)  0.75 (0.38-1.51) 
       
Dual method use 
post-ART initiation 
No 117 102(63.4) 15(62.5) 0.935  
Yes 68 59(36.7) 9(37.5)  1.04 (0.43-2.52) 
       
Current dual method 
use 
No 350 307(77.3) 43(74.1) 0.590  
Yes 105 90(22.7) 15(25.9)  1.19 (0.63-2.24) 
       
Time since HIV 
diagnosis 
0-12 months 244 215(54.2) 29(50) 0.553  











Table 6 Bivariate analysis: number of sexual partners in last 6 months (cont) 
  Sexual partners in the last 6 months   
  Total 0-1 >1 p- value OR (95% CI) 
      unadjusted 
       
CD4 count recall <=200 cells/µL 167 142(42.9) 25(61) 0.067  
<=350 cells/µL 106 96(29) 10(24.4)  0.59 (0.27-1.29) 
>350 cells/µL 99 93(28.1) 6(14.6)  0.37 (0.14-0.93) 
       
Disclosure status Did not disclose to 
someone 36 35(8.8) 1(1.7) 0.068  
Disclosed to 
someone 419 362(91.2) 57(98.3)  5.51(0.74-41.01) 
       
On ART No 270 236(59.5) 34(58.6) 0.905  
Yes 185 161(40.6) 24(41.4)  1.03 (0.59-1.81) 
       
Duration on ART Not on ART 270 236(59.5) 34(58.6) 0.823  
On ART (0-11 
months) 80 71(17.9) 9(15.5)  0.88 (0.40-1.92) 
On ART (12 or more 
months) 105 90(22.7) 15(25.9)  1.16 (0.60-2.23) 
       
Sexual activity post-
ART initiation 
More frequently 14 11(7) 3(12.5) 0.141  
Less frequently 35 28(17.8) 7(29.2)  0.92 (0.20-4.20) 
About the same 
frequency 132 118(75.2) 14(58.3)  0.44 (0.11-1.75) 
       
Number of sexual 
partners post-ART 
initiation 
0-1 partner 154 139(95.9) 15(71.4) <0.001  
>1 partner 12 6(4.1) 6(28.6)  9.27 (2.65-32.37) 
       
Quality of life - 
mobility 
No problems 236 206(51.9) 30(51.7) 0.718  
Some problems 203 176(44.3) 27(46.6)  1.05 (0.60-1.84) 
Confined to bed 16 15(3.8) 1(1.7)  0.46 (0.06-3.59) 
       
Quality of life - pain 
or discomfort 
No pain/discomfort 266 232(58.4) 34(58.6) 0.965  
Moderate 
pain/discomfort 162 141(35.5) 21(36.2)  1.02 (0.57-1.82) 
Extreme 
pain/discomfort 27 24(6.1) 3(5.2)  0.85 (0.24-2.99) 
       
Quality of life - 
feelings 
No 
anxiety/depression 50 314(79.3) 50(86.2) 0.432  
Moderate 
anxiety/depression 6 67(16.9) 6(10.3)  0.56 (0.23-1.37) 
Extreme 
anxiety/depression 2 15(3.8) 2(3.5)  0.84 (0.19-3.77) 
       
Quality of life - 
execution of daily 
activities 
No problem 370 321(80.9) 49(84.5) 0.835  
Some problems 81 72(18.1) 9(15.5)  0.82 (0.38-1.74) 
Severe problems 4 4(1) 0(0)  0 
       
Quality of life scale 
(tertile) 
1 173 142(35.8) 31(53.5) 0.033  
2 136 122(30.7) 14(24.1)  0.53 (0.27-1.03) 
3 146 133(33.5) 13(22.4)  0.45 (0.22-0.89) 
       
Service attended PMTCT 95 91(22.9) 4(6.9) 0.002  
VCT 64 58(14.6) 6(10.3)  2.35 (0.64-8.70) 
HIV Care 111 87(21.9) 24(41.4)  6.28 (2.09-18.83) 
ART Care 185 161(40.6) 24(41.4)  3.39 (1.14-10.08) 
















Table 7 Multivariate analysis: multiple partners in the past 6 months 
Variable Odds Ratio P value 95% CI 
Age 25-35 years (Ref: Age <25 years) 0.99 0.99 (0.30-3.28) 
Age >35 years 0.99 0.99 (0.28-3.57) 
Male (Ref: Female) 3.48 0.00 1.59-7.61) 
Secondary or tertiary education (Ref: No education/primary) 0.72 0.35 (0.36-1.44) 
Time since HIV diagnosis >12 months (Ref: ≤12 months) 1.30 0.42 (0.69-2.45) 
Disclosed status to someone (Ref: Not disclosed) 3.82 0.21 (0.47-31.20) 
Attending VCT (Ref: Attending PMTCT) 0.92 0.91 (0.22-3.84) 
Attending HIV Care 1.99 0.29 (0.56-7.13) 
Attending ART Care 1.13 0.85 (0.32-4.06) 
VAS composite scale 2 (Ref: VAS composite scale 1) 0.51 0.06 (0.25-1.04) 
VAS composite scale 3 0.68 0.33 (0.31-1.47) 
 
4.5 Conclusion 
The results above show high levels of sexual activity among this sample (61%). Men were half as likely 
as women to report sexual activity in the past month, and higher educational level was a significant 
predictor of decreased sexual activity. No significant differences in sexual activity were found between 
ARV-treated and treatment naïve participants or across health services. Furthermore, individuals who 
were on ARV treatment were three times as likely as those not on treatment to have used a condom 
during their last sexual event. Despite reporting lower levels of sexual activity, men were more than 
three times as likely to report more than one sexual partner in the past six months. These results are 












This thesis set out to examine the levels and determinants of sexual activity in HIV-infected, ARV 
treatment-naïve and treatment-experienced individuals accessing different primary health care service 
settings in Cape Town in 2006. It sought to determine predictors of sexual risk behaviour – notably 
unprotected sex and multiple partner acquisition – with a particular focus on whether or not disclosure 
or treatment status and time since diagnosis had a significant influence on sexual behaviour. 
Furthermore, this thesis examined the significance of HRQL as a correlate of sexual risk behaviour. 
5.1 Levels of sexual activity  
Higher levels of sexual activity were observed in this sample than found in similar studies in other 
African country settings, which reported sexual abstinence in the previous six months to be on average 
50% (Kennedy et al., 2007). In this study, about one third of participants reported sexual abstinence in 
the past month. These results concur with another Cape Town study of an HIV-infected sample both 
on and not on ART, where over 59.7% of men and 62.3% of women reported at least one sexual 
partner in the past month, with no significant differences being found between those on treatment and 
those not on treatment (Eisele et al., 2008). Extrapolating to population level, 47% of women 
respondents in the 2003 SADHS reported sexual activity in the past month (Department of Health et 
al., 2007). These results could suggest that sub-populations of HIV-infected South Africans may have 
higher levels of sexual activity than the general population, despite the maturing of the epidemic. 
Generalization is problematic, however. In a community survey of adults in a similar urban Cape Town 
setting with known high HIV prevalence, 93% of men and 94% of women had ever been sexually 
active, with 83% of men and 82% of women reporting that they were in a current sexual relationship 
(Boulle et al., 2008). Hence, such high levels of sexual activity could suggest potential regional 
differences or other exogenous factors play a role in determining levels of sexual activity.  
Levels of sexual activity appeared to be almost uniform across treatment status, suggesting that 
being on ART has neither a negative or positive influence on sexual activity among HIV-infected 
individuals in this sample. The lack of effect of ARV treatment on frequency of sex is similar to that 
found in Kampala, Uganda as well as results from Eisele et al‟s Cape Town study (Bateganya et al., 
2005, Eisele et al., 2008).  
In this study, univariate analyses showed that pregnant women accessing PMTCT services 
showed the highest levels of sexual activity in the sample. Having tested in pregnancy, women attending 
this service also comprised those with the shortest duration since HIV diagnosis. Fewer women 











past six months. Other data from South Africa, looking at teenage pregnancy, supports this finding, 
suggesting that pregnant women have sex more frequently than non-pregnant women, and may 
experience more coercive and dependent relationships than non-pregnant women (Jewkes et al., 2001).  
5.2 Determinants of sexual activity 
When adjusting for confounding factors, the sex of the respondent and level of education attained were 
the strongest predictors of sexual activity in the past month. Men were half as likely as women to report 
sexual activity, which is interesting in light of evidence from other research in Africa, where men have 
been found to be more sexually active than women (Moatti et al., 2003). Furthermore, those with a 
secondary or tertiary qualification were about as half as likely to have been sexually active in the past 
month. Possibly the results found here show the effect of communication campaigns on individuals 
who have more access to health promotion messages through educational channels. Time since 
diagnosis, disclosure status, and HRQL factors seemed not to have any bearing on sexual activity in this 
sample. 
5.3 Barrier method use and multiple partner acquisition 
Self-reported condom use at last sexual event was high (≥72%) among all respondents, regardless of 
service setting. However, reported condom use was significantly higher among those on treatment than 
those not on treatment, suggesting greater levels of awareness around safer sexual practice among 
treatment initiated individuals. It is thought hat high levels of condom use in other studies among 
ART-treated patients could be attributed to treatment literacy and elevated awareness of safer sex 
practices, through regular exposure in health care settings (Moatti et al., 2003). Furthermore, a greater 
proportion of ART-initiated respondents reported consistent condom use over the past six months 
than ART-naïve respondents. This trend held in the multivariate analyses: when controlling for 
confounding factors, condom use at last sexual act was significantly associated with attending an ART 
service. Income was associated with condom use at the 10% level, again suggesting that people with 
access to an income, who by proxy, may be more educated and more likely to be employed, may have 
had more exposure to health messages about safer sexual practices.  
These results add to other South African evidence that suggests different, multiple factors 
predicting unprotected sex among HIV-infected individuals within other study populations. In a study 
of rural and urban HIV-infected individuals, determinants of consistent condom use included urban 
residence, higher level of education and for women, disclosure status (Lurie et al., 2008). Eisele et al‟s 
study of treatment-naïve and treatment initiated HIV-infected respondents in a Cape Town urban 











of unprotected sex at last sexual intercourse included undisclosed serostatus to sexual partner as well as 
an ambivalence concerning the need for barrier methods when using ART. The latter factor was also 
the singular significant predictor for unprotected sex at last sexual intercourse with casual sex partners 
(Eisele et al., 2008). Attitudes towards dual method use were not explored in this study. However, 
univariate analysis at service level did show significant differences in dual method use, with dual 
method use being significantly higher among participants accessing ART. 
Multiple partner acquisition over the past six months differed between clinic settings. When 
stratifying by treatment status, however, there was no significant difference between those who were on 
treatment and those who were not. A higher proportion of ARV-treated respondents reported more 
sexual partners since diagnosis than those who were not on treatment, but when controlling for 
confounding factors, respondent sex was singularly the most significant predictor of multiple partner 
acquisition. Men had more than a 3-fold relative risk of having had more than one sexual partner in the 
past six months when compared to women. This finding is concurs with other South African evidence 
from community surveys, where the likelihood of men having more than one additional partner was 
reported to be greater than that of women (Boulle et al., 2008, Shisana et al., 2005).  
5.4 The association between sexual risk behavior and ARV treatment 
To summarise, no significant differences were found in levels of sexual activity between ARV-treated 
and treatment naïve respondents. As already stated above, individuals on ART were significantly more 
likely to have used a condom at last sex, however, no more likely than treatment naïve respondents to 
acquire more than one sexual partner in the past 6 months. 
5.5 The association between sexual risk behavior and HIV diagnosis, disclosure status and HRQL  
The time since HIV diagnosis and respondent‟s disclosure status were not significant predictors of 
condom use at last sex or multiple partner acquisition. This is an interesting finding in light of previous 
research into condom use among HIV-infected individuals. Olly et al found that unprotected sex at last 
encounter was associated with shorter duration of HIV infection and lack of disclosure (Olly et al., 
2005). Increased wellbeing, interpreted from the composite measure of HRQL, was significantly 
associated with multiple partner acquisition. This suggests that those who felt “more well” were more 













The high levels of sexual activity among HIV-infected individuals seeking a range of primary health 
care services in Cape Town, and the failure to detect major differences in sexual risk taking apart from 
condom use at last sex between those on ARV treatment and ART-naïve patients, has several 
implications for policy. First, there is an imperative to both increase, and make more widely targeted, 
behavioural risk reduction efforts across primary health care services, that specifically address the sexual 
health of HIV-infected individuals. Within this, communication campaigns which are tailored to gender 
specific needs are important. The fact that women in this sample were more sexually active than men, 
yet men were likely to have more than one partner than women, is suggestive that both sexes would 
benefit from different health messages.  
Second, more emphasis needs to be placed on the use of condoms among HIV-infected 
individuals who have not yet initiated treatment. Again, gender specific communication which takes 
account of the complexity of condom negotiation and use within sexual partnerships, is needed. 
Messages which promote and empower women to use self-protection through condom use are 
required. Tailored messages for pregnant women are imperative. Since these results show that women 
attending PMTCT services had the highest levels of sexual activity, and reported the highest levels of 
inconsistent condom use, it is important that they be exposed to interventions that allow them to 
protect their own health and the health of their unborn children. 
Third, prevention messages need to underscore the need for sexually active individuals to avoid 
frequent sexual partner turnover. This message is particularly important for men, who are at greater risk 
of having more than one partner over time than women. 
Fourth, to limit secondary transmission between HIV-infected partners and those of unknown 
status, behavioural interventions need to continue to promote population level HIV testing. The 
importance of both knowing one‟s serostatus and the sharing of results between partners should be 
highlighted, in order to limit secondary transmission risk. Furthermore, sexually active individuals need 
to be cautioned against having unsafe sex with partners of unknown HIV status. 
In conclusion, there remains a strong need for better understanding of the factors which 
influence the sexual risk behaviour of HIV-infected individuals in order to enhance prevention efforts.  
5.7 Limitations 
Sexual risk behaviour encompasses a broad range of sexual activity, and the obstacles to achieving valid 
measures of this activity are well documented. Three factors have been identified as important 
weaknesses in this study. First, social desirability bias and recall bias may have played a significant role 











sexual risk behaviour in such research. In general, the collection of sexual behaviour data has implicit 
challenges due to the private nature of sexual activity and its affiliation with moral, social, cultural and 
legal norms. These inherent features, which may be amplified by the stigma associated with HIV 
infection, give rise to measurement error and participation bias. Furthermore, there is no gold standard 
validity index for measuring such error and bias (Catania et al., 1990, Weinhardt et al., 1998). While 
steps were taken to minimize this bias through questionnaire design, question terminology and 
structure, the reliability of any sexual risk behaviour data has been shown to vary with several factors, 
including sex, age, ethnicity, the recall period and the number of previous sexual partners (Fenton et al., 
2001). It is plausible that the measurement of sexual risk behaviour in this study has been subjected to 
such error and bias, due to respondents reporting inaccurately either due to discomfort or 
embarrassment, or because of inaccurate recall of past events. 
Second, the use of a cross-sectional study design limits the ability to ascertain causal relationships 
between sexual risk behaviour and its correlates. Moreover, such surveys on sexual behaviour are not 
large enough to determine the prevalence of certain behaviours among sub-populations, such as HIV-
infected clinic attendees (Fenton et al., 2001). Without repeated measures, it is not possible to identify 
and monitor trends and behaviour change over time.  
Third, sexual behaviour can be measured with a variety of indicators as demonstrated in the 
abovementioned literature, some of which the design and content of the survey questionnaire did not 
cover. For instance, no provision was made for the measurement of certain known risk factors 
including the prevalence of concurrent sexual partnerships, transactional sex and crude determinants 
such as lifetime number of partners. Little data on the participants‟ partnerships themselves were 
collected, and it may have been useful to ascertain the age distribution of men and women in current 
sexual partnerships. Furthermore, misclassification of self reported exposure through the use of the 
generic term “sexual partner” did not allow for the distinction between paid, casual and non-casual sex 
partnerships. Also, this questionnaire had no content on substance use, which would have been useful 
in the examination of alcohol or drug use and its association with sexual risk behaviour. Furthermore, it 
is possible that the lack of association of HRQL factors with sexual risk behaviour arose due to poor 
specification in the instrument, and more sensitive measures of self-reported health and well-being may 
have elicited richer data. 
As with most forms of sociological, anthropological or behaviour-based research, the ability to 
extrapolate these results across social and economic classes in the same city – let alone across time and 
space – is intrinsically limited. The literature referred to in Chapter 2 described the conclusions drawn 
in similar studies around the globe. A common thread running through those studies was that multiple 











transmission. Such discrepancies between epidemic settings are integral in the appropriate shaping of 
prevention efforts to target secondary transmission. Hence, caution should be exercised in generalizing 
these results to inform broader policy recommendations. Yet, with the growth of interest in this area of 
research, and the continued scale-up and expansion of HIV treatment and care services in this setting, 
common patterns and modalities might become visible when comparing the results of this study with 
other, similar, studies examining secondary transmission risk of individuals accessing HIV and ART 
services over time.  
As the health of HIV-infected individuals who begin to access ART in South Africa becomes 
increasingly relevant, so the potential for more in-depth research into their sexual behaviour and 
reproductive health needs should be prioritized. More powerful designs which employ standardized 
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